Sie sind auf Seite 1von 51

ELSEVIER

Chemica-B~oiogical

Interactions

103 ( 1997) 7%

129

Mini review

A review of mechanisms underlying


anticarcin~genicity by brassica vegetables
Dorette T.H. Verhoeven**, Hans Verhagen,
R. Alexandra Goldbohm, Piet A. van den Brandtb,
Geert van Poppel
TN0

Nutrition and Food Research institute, P.O.Bas 360, 3700 AJ Zeist, The Netherkmds
hUniuersity of Limburg, ~@partm~nt of Epjdem~alag~, Maastricht. The Ne~~~rlunds

Abstract

The mechanisms by which brassica vegetables might decrease the risk of cancer are
reviewed in this paper. Brassicas, including all types of cabbages, broccoli, caulitlower and
Brussels sprouts, may be protective against cancer due to their relatively high glucosinoiate
content. Glucosinolates are usually broken down through hydrolysis catalyzed by myrosinase, an enzyme that is released from damaged plant cells. Some of the hydrolysis products,
viz. indoies and isothiocyanates, are able to influence phase I and phase 2 biotransfor~tion
enzyme activities, thereby possibly influencing several processes related to chemical carcinogenesis, e.g. the metabolism, DNA-binding
and mutagenic activity of promutagens. A
reducing effect on tumor formation has been shown in rats and mice. The anticarcinogenic
action of isothiocyanates and indoles depends upon many factors, such as the test system, the
target tissue, the type of carcinogen challenge and the anti~rcinogeni~
compound, their
dosage, as well as the timing of the treatment. Most evidence concerning anti~arcinogenic
effects of glucosinolate hydrolysis products and bras&a vegetables has come from studies in
animals. Animal studies are invaluable in identifying and testing potential anticarcinogens. In
addition, studies carried out in humans using high but still realistic human consumption
levels of indoles and brassica vegetables have shown putative positive effects on health. 6
1997 Elsevier Science Ireland Ltd.
Ktywords:

Anticarcinogenesis;

Brassica vegetables; Glucosinolates;

Indoles: Isothiocyanates

* Corresponding author. Tel.: + 31 30 6944755: fax: -i- 31 30 6957952.


000%2797/97/$17.00 Q 1997 Elsevier Science Ireland Ltd. All rights reserved
PlI SOOO9-2797(96)03745-3

80

D.T.H.

Verhoeven et al. 1 Chemico-Biological Interactions 103 (1997) 79-129

1. Introduction

The hypothesis that certain components of plant foods are protective against
cancers at many sites has gained interest in the past two decades and is supported
in many studies [l-3]. A large number of potentially anticarcinogenic agents have
been suggested in fruits and vegetables so far, e.g. fiber, vitamins C and E,
carotenoids, flavonoids, phenols, phytoestrogens, diallylsulfides, limonene and hydrolysis products of glucosinolates. The mechanisms by which these agents may act
include dilution and binding of carcinogens in the digestive tract (fiber), antioxidant
effects, inhibition of nitrosamine formation, inhibition of activation of promutagens/procarcinogens,
induction of detoxification enzymes, alteration of hormone
metabolism, and others [4-61.
One group of vegetables that has been widely regarded as potentially cancer
protective are vegetables of the Cruciferae family. Cruciferous vegetables are the
major source of glucosinolates in the diet which distinguishes them from other
vegetables. Brassica vegetables, including all cabbage-like vegetables, are a genus of
the family Cruciferae and contribute most to our intake of glucosinolates [7]. In the
1960s interest emerged in the possibility that certain aromatic and indolic glucosinolate hydrolysis products might influence carcinogenesis. In in vivo experiments
animals were fed glucosinolate hydrolysis products together with a carcinogen and
it was found that fewer animals developed tumors in comparison with control
animals not receiving the glucosinolate hydrolysis products [8,9]. From that time on
many studies have been carried out to examine the possible anticarcinogenic effect
of brassica vegetables and glucosinolate hydrolysis products. This paper now
reviews these experimental studies investigating the effects of brassica vegetables
and glucosinolate hydrolysis products on carcinogenesis and cancer risk.
Searches for papers on brassica vegetables, glucosinolates or hydrolysis products
of glucosinolates were carried out with MEDLINE on CD-ROM (1983-1996),
with Current Contents (1995- 1996), and by checking references to find earlier
reports.
This paper will give a short overview of the occurrence and intake of glucosinolates, and of the chemistry of glucosinolates and their hydrolysis products. This will
be followed by the putative beneficial properties and adverse effects of brassicas,
glucosinolates and their hydrolysis products. Finally, an overall conclusion and
suggestions for further research will be given.

2. Occurrence and intake of glucosinolates


So far, over one hundred glucosinolates have been identified which occur
predominantly, but not exclusively, in vegetables of the family Cruciferae [lo]. In
Table 1 an overview is given of common vegetables of the family Cruciferae.
Vegetables of the genus Brassica, in which 15-20 glucosinolates have been found,
contribute most to our intake of glucosinolates and include all kinds of cabbages,
kale, broccoli, cauliflower, Brussels sprouts, kohlrabi, rapeseed, rutabaga and

turnip. Detailed information on the consumption of brass&as is not readily


available. In Table 2 the ~ons~ption
of some brassicas, as determined from food
cons~ption
surveys in the UK [I l] and in the Netherlands [ 121, in 1992 is given.
The glucosinolate content of plants depends upon variety, cultivation conditions.
climate and the agronomic factors associated with plant growth, while the levels in
a particular plant vary between the parts of the plant [7]. Indolglucosinolates are
found in young shoots and growing leaves [17]. The total glucosinolate content of
a variety of brassica vegetables is also shown in Table 2. Very little is known about
the average daily intake of glucosinolates. An intake of 12- 16 mg glucosinolates
per person per day has been suggested by Fenwiek and I-Ieany [IO].

3. Chemistry of gluc~inolates and their hy~olysis products


3.1. Chemical structure
The chemistry of glucosinolates and their hydrolysis products has been reviewed
extensively by Fenwick and Heany [7,10]. All glucosinolates share a common basic
skeleton containing a j?-r>-thioglucose grouping, a side chain and a sulfonated
oxime moiety, but differ in side chain (R):
S - p - D glucose
/
R-C
\\
N-OSO,-with R = alkyl, alkenyl, arylalkyl, alkylthioalkyl,

a-hydroxyalkyl

or indolylmethyl.

Table 1
Common vegetables of the family Cruciferae
Genus

Species

Common name

Armoracia

Rusticana

Brassica

C~~esr~is

Horseradish
Turnip
Pak choy
Brown mustard
Rape, Swede, rutabaga
Black mustard
Cabbage, kale, Brussels sprouts, cauliflower. broccoli. kohlrabi
Chinese cabbage
Garden cress
Watercress
Radish
Mustard

_-...-._.__

~kine~s~s
Juncea
Napus
Nigra
Oleracea
Pekinensis
Sativum
O~~~ina~e
Satiw
Aha

11

1
10
1
2

4
12

3 (Sauerkraut)

Netherlands [ 121

UK [ll]

Consumption of bras&as
(g/person/day)

;LJ

f?
$j.
2
94-1111 [13]
372 [13]
691 [13]

138-2083 [13], 530-1140 [16], 122 [14]


611 1131,276 [14]
894 [13]
-

z
i2

;
a
;.
6

-G
F
3
K

c%
B
;I;
2
F

205-944 [13]

597-2542 114, 1628 [IS]

548 [13]

Level of total glucosinolates in cooked


vegetables (mg/kg fw)

5G

392-1657 [13], 260 [lo]

PO1

669 [13], 410-1090 [IO]


510 [14], 330-840 [lo]
470-1240 [lo]
170-1360 [IO]
145553939 114, 2562 Il.5). 1342 1141,600-3900

Level of total glucosinolates in unprocessed


vegetables (mg/kg fw)

The analyses were conducted in the following countries, with the references in brackets: UK ([lo] only Brussels sprouts, [13, 161);USA ([lo] except Brussels
sprouts); Canada [ 141;Netherlands [ 151.

Turnip-Swede
Cauliflower
Broccoli
Kale
---

Cabbage
Red
White
Savoy
Chinese cabbage
Brussels sprouts

Vegetable

-_

Table 2
Consumption of some brassica vegetables and reported ievels of total glucosinolates in unprocessed and cooked brassica vegetables

D.T.H.

Verhoeven et al. / Ch~~i~~-%~o~o~i~alInteru~ti~tls IO.? [i997] 19-i-79

83

Glucosinolate hydrolysis products make a significant contribution to the typical


flavour of brassica vegetables. The enzyme myrosinase (thioglucoside glycohydrolase EC 3:2:3:1) catalyses the hydrolysis of glucosinolates [lo]. Myrosinase is found
in plant cells in a separate compartment from glucosinolates. When the plant cells
are damaged, e.g. by cutting or chewing, the myrosinase comes in contact with the
glucosinolates and hydrolysis occurs. All kinds of processing lead to a certain
degree of glucosinolate hydrolysis by myrosinase hydrolysis or other chemical
reactions. The effects of processing on glucosinolate levels in vegetables have been
reviewed by De Vos and Bhjleven [18]. When the vegetables are cooked, myrosinase
is inactivated and thermal degradation and wash out occur, leading to a 30 --60(X1
loss of intact glucosinolates.
It should be noted that myrosinase activity has also been found in certain
intestinal microflora. This could be of importance when intact glucosinolates are
digested, although very little is known about this metabolic pathway [lo].
The glucosinolate hydrolysis products consist of equimolar amounts of an
aglucon, glucose and sulphate. The aglucones are unstable and undergo further
reactions to form for instance thiocyanates, nitrites or isothiocyanates. The nature
of the hydrolysis products depends primarily on the side chain of the glucosinolate,
besides the conditions of the hydrolysis and the presence of any cofactors. Glucosinolates with an indole side chain form indoles, whereas oxazolidine-2-thiones are
formed from glucosinolates with a ~-hydroxy-alkyl side chain. Table 3, derived
from De Vos and Blijleven [1X], shows some glucosinolates and their hydrolysis
products that occur in cruciferous vegetables,
Of the indole glucosinolates, which are predominant in brassica vegetables,
glucobrassicin is amongst the most prevalent. At neutral pH glucobrassicin forms
an unstable isothiocyanate which degrades to indole-3-carbinol (13C) and a thiocyanate ion. I3C may condense to 3,3-diindolylmethane (DIM) or react with
ascorbic acid to form ascorbigen. At a more acidic pH, glucobrassicin forms
indole-3-acetonitrile (13A) and elemental sulphur [7,17]. In many publications it was
suggested that 13C and I3A were the most abundant metabolites, but recently it has
been stated that ascorbigen is the major indole-containiIlg product of gluco-brassicin biotransformation
[19].
3.3. Analysis

qf glucosinoiate composition und content

The analysis methods for determining glucosinolate composition and content


have been reviewed by McGregor et al. [20]. Distinction has been made between
total glucosinolates, individual glucosinolates and hydrolysis products. For determination of total glucosinolate content, calorimetric measurement of glucose released
by myrosinase hydrolysis seems most appropriate. Both gas-liquid chromatography
(GLC) and high performance liquid chromatography
(HPLC) can be used to
determine the content of individual glucosinolates. Because of the thermal instability of indolglucosinolates, HPLC is the most suitable method for determination of

Glucocochicarin
Sinigrin
Gluconapin
Glucobrassicanapin
Progoitrin
Gluconapoleiferin
Glucoiberverin
Glncoiberin
Gluc~heiroli~
Glucoerucin
Glueoberteroin
Glueotropaeolin
GIuconastu~un
Glu~brass~cin
Neo-glucobrassicin

Trivial name

+
+
+
+
+
t
+
+
+
+
+
+
+
i+

Nb

c
+
f lndoles
+ Indoles

-I-

-I-

c
+
c

Tb
-

i
i

Xb

Myrosinase hydrolysis products


_-_

Reproduced with permission from De Vos and Blijleven [18].


bN, Nitrile, R-C=N;
I, isothiocyanate, R-N = C = S; T, thiocyanate ion, S-C zN.
CGeneral structure: R-C=N
witb sulphur inserted in the terminal double bond of R.

2-Butyl
2-Propenyl
3-Butenyl
4-Pentenyl
2-Hydroxy-3-butenyl
2Hydroxy-~~nteny1
3Methyltbiopropyl
3-Methylsulfinylpropyf
3-Methylsulfonyipropyl
4-~ethylthjobutyl
5-Methylthiopentyl
Benzyl
2-Phenylethyl
3-Indolylm~thyl
I-Methoxy-3-indolylmethyl

Side chain (R) =

Table 3
Some glucosinolates and their hydrolysis products found in brassica
-__
--

.~

.-

Epithionitrilec
Epithionitrih?
Epithionitrilec
L-5-vinyl-oxazolidine-2-thione
L-~-ailyl-oxazol~dine-2-thione,

Others

1-

(goitrin), Epithionitrile~
~pithionit~lec

_-

5
2

!k?
%
5
B

r*l
ms
3
F;
D

7
&
%
3
b

P
3
3

D.T.H.

Verhoeuw et al. / ~hemico-Biol~gi~ul I~ter~~ti~~ 103 (1997) 79-129

85

these compounds. rsothiocyanates and nitriles can be analyzed by GLC. HPLC


with UV detection may be used for analysis of oxazolidinethiones and indoles.

4. Putative beneficial properties of glucosinolate hydrolysis products and brassicas


4.1. Postulated mechanism of anticarcinogenic action
Carcinogenesis is a multistage process; cells susceptible to genetic changes
(initiation) and epigenetic changes (promotions may gain a growth advantage and
undergo clonal expansion. Genetic changes are considered to result from interactions between DNA and a carcinogen/mutagen, which can be metabolised into an
electrophilic intermediate and bind to DNA. If repair of the damage does not
occur, replication of DNA can lead to permanent DNA lesion, and in presence of
a tumor promotor to preneoplastic cells, neoplastic cells and finally metastases [21].
At each stage of the carcinogenic process a possibility of intervention exists. One
anticarcinogenic action is the modulation of metabolism of carcinogenic/mutagenic
compounds, thereby preventing the formation of electrophilic intermediates. This
modulation of metabolism comprises inhibition of activation of promutagens/procarcinogens, induction of detoxifying mechanisms, and stimulation of activation
coordinated with detoxification and blocking of reactive metabolites [22]. Involved
in this modulation are phase 1 and phase 2 biotransfo~ation
enzymes [23]. Phase
1 involves oxidation, reduction and hydrolysis reactions, thereby making xenobiotics more hydrophilic (which can result in inhibition of activation but also in
activation of the compound) as well as susceptible to detoxification. The most
important phase 1 enzymes are the cytochrome P450 enzymes. Phase 2 metabolism,
a detoxifying mechanism, comprises conjugation reactions making phase 1 metabolites more polar and readily excretable. Examples of phase 2 enzymes are
glutathione S-transferases and UDP-glucuronyl
transferases. Alteration of biotransformation enzyme activities is supposed to be involved, at least partly, in the
alteration of the toxicity, mutagenicity and tumorigenicity of specific chemicals [24].
Isothiocyanates and indoles, both glucosinolate hydrolysis products, are considered to be able to modulate biotransfo~ation
enzyme activities ]17,24-261. Indoles
thereby also affect estradiol metabolism, which is P450 dependent, and may reduce
the risk of estrogen-dependent
diseases such as mammary cancer [27]. Besides
modulators of biotransformation
enzymes isothiocyanates are seen as suppressing
agents [6,28]. Suppressing agents act during the promotion phase of the neoplastic
process via prevention of the evolution of the neoplastic process in cells.
4.2. Results of studies on anticarcinogenic action
In Tables 4-8 the results of studies on the antimutagenic and anticarcinogenic
properties of isothiocyanates, indoles and brassica vegetables are presented. A
distinction has been made between in vitro and in vivo studies. One of the most

In vivo, mouse
In vivo, rat
In vivo, rat

I3C

13C, RXM

I3C, I3A, DIM, ascorbigen,


13CHO
Brussels sprouts, I3C

Benzo[u]pyrene hydroxylase

Aniline p-hydroxylase
Aryl hydrocarbon
hydroxylase

MSPITC
13C, I3A
I3C, DHII, THII
I3C, DHII
Cauliflower
BylITC, BITC, ButITC, PPITC

Brussels sprouts
Brussels sprouts, cabbage
Cabbage
Cauliflower
Broccoli
Brussels sprouts, cabbage,
I3C, I3A, DIM
Brussels sprouts, cabbage,
broccoli, cauliflower, turnips

vivo,
vivo,
vivo,
vivo,
vivo,
vivo,

rat
mouse
rat
rat
rat
rat

In vivo, rat

In
In
In
In
In
In

In vivo, rat

rat
mouse
rat
mouse
rat
rat

In
In
In
In
In
In

BylITC, BITC, ButITC, PPITC


vivo,
vivo,
vivo,
vivo,
vivo,
vivo,

In vivo, in vitro,
rat
In vivo, in vitro,
rat
In vivo, rat

PEITC

Alcohol dehydrogenase
Aldehyde dehydrogenase
Aminopyrine Ndemethylase

PEITC

Test systemi

Compound/vegetable

indoles and brassica vegetables

Phase 1 enzyme

Table 4
Alterations of phase 1 enzyme activities by isothiocyanates,

t Small intestine (Brussels sprouts>


cabbage > turnips > broccoli > cauliflower

] Liver, when compounds were given p.o.


-+ Liver, when compounds were given i.p.
t Liver > small intestine; ascorbigen least
effective and not by 13CllO
t Intestine, + liver
+ Intestine, + liver
r Small intestine
-+ Liver
t Intestine, -9 liver
-+ Liver
t Liver
1 Small intestine

+ Liver

+ Liver, + small intestine


+ Liver, both given i.p. and p.o.
+ Liver
t Liver only by 13C
t Liver
1 Liver, not by ButITC

1 Liver

1481

[41
1421
[431
PI
1451
[361
[461
1471

1401

1391

[37,381

1321
1331
[341
[351
[361
[31

131

[301

[301

+ Liver
1 Liver

Refs

Effect

N-

7-Ethoxycoumarin
O-deethylase

Estradiol 2-hydroxylase

Cyclooxygenase
Erythromycin Ndemethylase

~enzphetamine
demethylase

WI
[531
1541
[55,561
1571

t Colon
1 Liver
J. Liver
t
t, Only in estrogen-responsive

In vivo, rat
In vivo, rat

[501
1321
1641
1511
WI
[471
I411
[421
[431
t451

T Liver
+ Small intestine, -+ liver
4 Liver
+ Liver
7 Liver
1 Small intestine
1 Intestine, -+ liver
+Intestine, --) liver
t Small intestine
t Intestine. -+ liver

In vivo, rat
In vivo. rat
In vivo. rat

Brussels sprouts
Cabbage

In vitro, chick
embryo
In vivo. rat

rat
rat
rainbow trout
rainbow trout

In
In
In
In

vivo,
vivo,
vivo,
vivo,

l581
1591
[6Wll
[621
[631
[491

t2-hydroxylation, + 16~-hydroxylation
t Liver
f Liver
t Liver (DIM > 13C)
1 Liver
1. Liver

Brussels sprouts, cabbage,


13C, 13A, DIM
Brussels sprouts, 13C

BNITC
MSPITC
I3C
13C, 13-ethanol, Kaldehyde,
13-acetic acid
13C, I3A

13c
13c
13C
13C, DIM
13C ascorbigen
ANITC

13c

In vivo, rat
In vitro, mouse, mammary epithelial cells
In vitro, estrogenresponsive and estrogennonresponsive human
breast cancer ceils
In vitro, MCF-7 cells
In vivo, rat
In vivo, mouse
In vivo, rat
In vivo, rat
In vivo. rat
cells

WI
[331
1511

t Liver
+ Liver, both given i.p. and p.o.
+ Liver, 1 liver only by I3-aldehyde

In viva, rat
In vivo, mouse
In vivo, rainbow trout

BNITC
13C, 13A
13C, I3-ethanol, 13-aldehyde,
I3-acetic acid
PHITC
BITC, PEITC, PBITC,
PHITC
PEITC
13C

1491

vivo.rat
1 Liver

In

ANITC

7-Ethoxyresornfin
deethylased

P450 IA1

N-nitrosodimethylamine demethylase

O-

In vivo, rat
In vivo. rat

In vivo, rat
In vivo, mouse
In vivo, rat
In vivo, mouse
In vitro, estrogenresponsive and estrogen
nonresponsive human
breast cancer cells
In vivo, rainbow trout
In ovo, rainbow trout
embryos; in vivo,
fingerling trout, liver
In vivo, mouse

Cauliflower
BITC, PEITC, PBITC,
PHITC

PEITC
13C
13C, DHII, THII
13C, DHII
13C

1541
[531
F51
[331

1 Liver, 1 nasal mucosa, --$ lung


1 Liver
7 Liver
-+ Liver when given i.p.; 1 Liver
when given p.o. (13C>13A)
-) Liver
1 Liver, but only weak and transient
1 Liver at low doses and 1 liver at
high doses

In vivo, rat
In vivo, rat
In vitro, chick embryo
In vivo, mouse
In vivo, rainbow trout
In vivo, rainbow trout
In vivo, rainbow trout

PEITC
BITC, PEITC, PBITC,
PHITC
13C, 13A
I3C. 13A

f3C
13C
13C

WI
1671
1691

WI

t Liver, but only weak and transient


1 13C showed relatively weak induction

1671
1671

[54&o]
[3gl
1341
[351
[571

1 Liver
-* Liver
1 Liver, only by DHII
-+ Liver
t, Only in estrogen-responsive

cells

1361
[531

t Liver, only by 13C (given p.o. z


given i.p.)
1 Liver
1 Liver

T Liver

PEITC

13C
132, DIM, CTI, RXM

In vivo, rat
In vivo, mouse

PHITC
13C, 13A

1521
1331

PO1

t Liver

In vivo, rat

f Colon

[471

1 Small intestine, not by 13A

In vivo, rat

Brussels sprouts, cabbage,


I3C, I3A, DIM
PEITC

Hexobarbital hydroxylase
Lactate dehydrogenase
Lipoxygenase
p-Nitroanisole Odemethylase

Refs

Effect

Test systemb

Compound/vegetable

Phase 1 enzyme

Table 4 (continued)

7-Ethoxyresorufin
Odeethylased

Sin&in, progoitrin, glucobrassicin, glu~otropaeolin

ICZ

ICZ

t Small intestine, only by ~lucobr~sici~,


liver, + large intestine

-+

[771

f and 1. concentration

dependent

1761

In vitro, Hepa lclc7


murine hepatoma cells
In vitro, Hepa lclc?
murine hepatoma cells
In vitro, human breast
cancer cells
In vivo, rat

ICZ

In vivo. rat

rat
rat, monkey
rat
mouse
rat

13C, NI3C, NCHO, DIM,


indole, 3M1, 13CH0, 13A

vitro,
vitro,
vivo,
vivo,
vivo,

In
In
In
In
In

13C, I3A, DIM, 13CHO


DIM, CTI, BII
13C, DHII, THII
13C, DHII
13C, RXM

1791

[781

1751

[711
[741
I341
1351
1391

f731

[@I
[701
1711
1721

1 Liver
1 Liver
1 Liver, t small intestine
-+ When cotreated with 2,3,7,8-tetrachlorodi~nzo-~-dioxin:
decrease in
induced EROD activity
I3C:t (Liver > small > large intestine)
DIM + 13A:f liver, -t small + large intestine
ascorbigen: + liver, 7 small + large intestine
t Liver, not by 13C and 13CHO
t Liver
t Liver
t Liver
13C + RXM, p.o.: f (small intestine > lung r
liver) 13C, i.p.: -+
RXM, i.p.: t (lung>hver), -+ small intestine
p.o.: 1 Liver, not by indole, 3M1, 13CH0,
I3A
13C, i.p.: + liver
RXM, i.p. or p.0.: t liver

In vivo, mouse
In vivo, rat
In vivo, rat
In vitro, human breast
cancer cells
In vivo, rat

[511

-+ Liver

In vivo. rainbow trout

13C, 13A, DIM, ascorbigen

I3C, I3-ethanol, 13-aldehyde,


13-acetic acid
13C
I3C
13c
I3C, DIM

In vivo, rat
vivo,
vivo,
vivo,
vivo,
vivo,
vivo,
vivo,
vivo,
vivo.

In
In
In
In
In
In
In
In
In

In vitro, human P450 IA2


expressed in Escherichia roli
In vitro, human P450 IA2
expressed in Escheric~hiu coli
In viva, rat
in vivo, rat
In vivo, rat
In vivo, mouse
In vivo, rat

Cabbage

Brussels sprouts
Brussels sprouts
f3C
13c
13C

13c
13C, DIM
Brussels sprouts

PEITC

PEITC

13c
Brussels sprouts
Broccoli

PEITC

PEITC

P450 IA2

Methoxyresorufin
0-dealkylased

P450 2B

P450 IAI, I450 IA2

In vivo. rat

Cabbage

rat
rat
rat
rat

rat
rat
rat
rat
rat

Test systemb

Compound/vegetabIe~

Phase 1 enzyme
-7-Ethoxyresoru~n
O-deethylase

Table 4 ~continued)
--.--

1 Liver, -+ lung, $ nasal mucosd

T Liver
-t Liver, t small intestine
P450 28 mRNA: -+liver, 1 colon
P450 28 protein: t liver, 1 coion
1 Liver

1 Small intestine, -+ large intestine,


-8 liver
t Small intestine, 1 liver
t Small & large intestine, t liver
t Liver
t Liver, -+ small intestine
P450 1Al: t liver, t colon
P450 1A2: j liver, -+ colon
t Liver
t Liver
t Liver, -+ small intestine
P450 1AI mRNA: t liver, t colon
P450 IA1 protein: t liver, t colon
P450 IA2 mRNA: t liver, colon not
detectable
P4SO IA2 protein: t liver, + colon
1

__t (Small intestine z large intestine > liver)

EffectC

[541

F41
[621
FOI
WI

1831

Refs
-

cl
b
3
f
?
!$
ZY
09
8
k

13

Brussels sprouts
13c
13C
13c
PEITC
Brussels sprouts,
I3C, 13A, DIM
PHITC

P450 3A
P450 3Al
P450 3AI/2

P450 3A2, P450 4Al


Phenacetin
O-dealkylase
Phospholipase
A2
cabbage,

In
In
In
In
In
In

PEITC
PEITC
Sulforaphane
13C
Broccoli

P450 2El

P450 2D6

P450 2CI 1

P450 2B112

rat
rat
rat
rat
rat
rat

rat
rat
rat

rat

mouse

In viva, rat

vivo,
vivo,
vivo,
vivo,
vivo,
vivo,

In vivo,
In vivo,
In vivo,
In vivo,
In vivo,
In vivo,
In vivo,
In vivo,
In vivo,
In vivo,
In vitro,
somes
In vivo,
In vivo,
In vitro,
In viva,
In vivo,

P450 2Bl

rat
mouse
rat
rat
rat
rat
rat
rat
rat
rat
human
micro-

1801
1821
WI
1841
1301
1471
1521

T colon

1681
1301
1891
1841
1851

T Liver, 1 lung
1 Liver, after elevation by ethanol
1 Liver
+ Liver
T P450 2E1 proteins liver
+ colon
+ Liver, -+ small intestine
t Liver
T Liver
+ Liver
-+ Liver
t Small intestine, not by DIM

1801
1681
1301
1821
1711
1811
1841
1621
1301
VII
WI

1711
1391

T Liver, T small intestine


T Liver, when 13C was given p.o.,
small intestine,
+ lung
r Liver, 1 small intestine
t Liver, 1 lung
T Liver
t Liver
t Liver, T small intestine
1 Liver
T Liver
T Liver
5_Liver
+ Liver
1 Liver

In vivo, rat
In vivo, rat
+

1531

1 Liver

In vivo. rat

BITC, PEITC,
PHITC
13c
13C, RXM

PBITC,

WI

T Liver

rat

In vivo,

PEITC

Brussels sprouts
PEITC
PEITC
13c
13C
13C
13C
13C, DIM
PEITC
13C
PEITC

7-Ethoxyresorufin
O-dealkylased

I Liver, 1 small intestine, t


esophagus, t forestomach
I (small intestine > forestomach >
liver > lung > kidney), + colon, 1
urinary bladder
7 Liver, + lung, + nasal mucosa
T Liver
t Small intestine, + liver
Erwin: T (small intestine > forestomach > glandular stomach > liver > lung)
Sulforaphane: r (glandular stomach >
small intestine > forestomach > liver), +
lung
Erysolin: + small intestine, +
forestomach, -+ glandular stomach, +
liver, + lung

In vivo, mouse
In vivo, mouse

In vivo, rat
In vivo, rat
In vivo, rat
In vivo, mouse

BITC

PEITC
BylITC, BITC, ButlTC,
PPITC
MSPITC
Erucin, sulforaphane,
erysolin

I Liver
+ Liver
I Liver
I Intestine, only by Brussels sprouts
I Small intestine
1 Liver, only by Brussels sprouts
t Liver, -+ intestine
I Liver
I Esophagus, 7 stomach
1 Liver, not by THII
I Liver, not by THII
+ Liver
I Esophagus, t colon, -+ liver, +
stomach
I Liver, + lung, + nasal mucosa

In vivo, rat

rat
rat
rat
rat
rat
mouse
rat
rat
rat
rat
rat
mouse
rat

BITC, PEITC, PBITC,


PHITC
BITC

Glutathione reductase
Glutathione-S-transferase

Glutathione peroxidase

vivo,
vivo,
vivo,
vivo,
vivo,
vivo,
vivo,
vivo,
vivo,
vivo,
vivo,
vivo,
vivo,

In
In
In
In
In
In
In
In
In
In
In
In
In

ANITC
BNITC
I3C
Brussels sprouts, 13C
Brussels sprouts
Brussels sprouts, cabbage
Cabbage
Broccoli
PEITC
I3C, DHII, THII
13C, DHII, THII
PEITC
PEITC

Epoxide hydrolase

Effect

Compound/vegetables

Test systemb

indoles and brassica vegetables

Phase 2 enzyme

Table 5
Alterations of Phase 2 enzyme activities by isothiocyanates,

1951

~321

[541
1311

1941

[91-931

1531

1341
WI
[901

t901
t341

z
2
g
3

2
2.
P

D
3
r?
0
r;l
6
s
oq.
s
$

,:
%
B
tz
3
2
Q
L-

1411
1431
WI
1451
t461

P
!-I
3

[491
1501
1821

Refs

NAD(P)H-quinone reductase,
also named NAD(P)H-quinone
oxidoreductase, DT-diaphorase

Glutathione-S-transferase

I531
[loll

T Liver, -+ lung, -+ nasal mucosa


T (small intestine z lung> forestomach >
urinary bladder > kidney > liver > colon)

In vivo, rat
In vivo, mouse

BITC, PEITC, PBITC,


PHITC
BITC

[451
[461
w01
WI

In
In
In
In

Cabbage
Broccoli
Rapeseed
PEITC

vivo,
vivo,
vivo,
vivo,

rat
rat
germ-free rat
mouse

Wl
I431
[991

~421

In vivo, rat
In vivo, rat
In vivo, rat

[411

1 Liver & intestine only by Brussels


sprouts
-+ Liver, t intestine only by Brussels
sprouts
t Liver, T small intestine
T small intestine
t Liver, T small intestine, -+ large intestine
T Liver, 1 intestine
T Liver
-+ Liver
-+ Liver, -+lung

vivo, rat
ovo, chick embryo
vivo, rainbow trout
vivo, rat
vivo, rat
vitro, rat
vitro, rat, monkey
vivo, rat
vivo, mouse
vivo, mouse

Brussels sprouts
Brussels sprouts
Brussels sprouts

WI
l971
WI
PSI
1711
1711
[74l
[341
[351
[931

7 Liver
-9 Liver
-+ Liver
t Liver
t Liver, t small intestine
t Liver
+ Liver
t Liver, not by THII
1 Liver
1 Liver, 7 small intestine

In
In
In
In
In
In
In
In
In
In
In vivo. rat

[961

t Liver, t small intestine

In vivo, rat

AITC, goitrin, Brussels


sprouts
13C
13C, 13A
13c
I3C
13C
I3A, DIM, 13CHO
DIM, CTI, BII
13C, DHII, THII
13C, DHII
13C, 13A, cabbage,
Brussels sprouts
Brussels sprouts, I3C

In vitro, Hepa lcIc7 murine


hepatoma cells

In vitro, Hepa lclc7 murine


hepatoma cells
In vivo, mouse

Glucosinolates with(out)
myrosinase, at pH 6.6
or pH 3.t

Erucin, su~foraphane,
erysohn
Erucin, sulforaphane,
erysohn

Erucin: I (smati intestine > Iiver >


gtanduiar stomach > lung > forestomach),
SnIforaphane: 1 (iiver > glandular
stomach = smafi intestine >
forestomach > lung),
Eryaohn: I liver, -) forestomach, -+
glandular stomach, -+ small intestine, -+
lung

t Liver, 7 forestomach, t gIanduIar


stomach, I small intestine
Without myrosinase, pH 6.6: phydroxybenzyl and 2-hydroxybut3-enyI ghrcosinolates induced
activity; with myrosinase at pH
6.6: breakdown products induced
activity (3-methyIsuIphinylpropyl > prop2enyi spent-4enyl + 2-phenethyl t benzyl 3 all
others; without myrosinase,
pH 3.1: breakdown products induced activity (3methyfsulphinyIpropyl + 2-phenethyi > bennyi > all
others
f

1 Liver
t Liver
T Small intestine, + liver
t

In vivo, rat
In vivo, rat
In vivo, rat
In vitro, Hepa lclc7 murine
hepatoma cells
In vivo, mouse

ANITC
BMTC
MSPITC
Ketoisothiocyanate

[951

[IO31

[491
[501
[321
[~021

I541

7 Liver, +Iung,

In vivo, rat

PEITC

NAD(P)Hquinone reductase,
also named NAD(P)H-quinone
oxidoreductase, DT-diaphorase

--t nasal mucosa

Refs

Effect=

Test systemb

Compound/veg~table~

---_

Phase 2 enzyme

Table 5 (continued)
g

~~__

vivo, rat
vivo, mouse
ovo, chick embryo
vivo, mouse
vivo, germ-free rat
vivo, rat

In
In
In
In
In
In

13C, DHII, THII


13C, DHII
13C, 13A
13C, 13A
Rapeseed
Brussels sprouts

rat
rat
rat
rat
rainbow trout
rat

WI

uw

1331

WI

1341
1351

vivo,
vivo,
vivo,
vivo,
vivo,
vivo,

In
In
In
In
In
in

1 Liver, ] nasal mucosa, -t lung


1 Liver, only by I3C
t Liver, -+ lung, -+ nasal mucosa
3 Liver, + small intestine
-+ Liver
Glucuronyl transferase towards 4ehlorophenoi: T liver, -+ small intestine,
Glucuronyl transferase towards 4-hydroxybiphenyl: --) liver, -+ small intestine
t Liver, not by THII
t Liver
T Liver
-+ Liver, both given i.p. and p.o.
-+ Liver
t Liver

-+ Liver, both given i.p. and p.o.


1331
1 Liver, in monkey hepatocytes only by BII [74]
t Liver, not by THII
[341
7 Liver
135J
t Liver, 1 small intestine
1801
1, except by cauliflower
1104j

mouse
rat, monkey
rat
mouse
rat
hepa lclc7 cells

vivo,
vitro,
vivo,
vivo,
vivo,
vitro,

In
In
In
In
In
In

CTI,

BII
I3C, DHII, THII
13C, DHII
Brussels sprouts
Brussels sprouts, cauiiflower, cabbage, broccoli
PEITC
13C, DHII, THII
PEITC
MSPITC
I3C
13C

DIM,

I3C, I3A

(711

1 Liver, 1 small intestine

In vivo, rat

I3C

ANITC, r-naphthyl isothiocyanate; BII, 2,3~bis~3-indolylmethyl]indole, an acid condensation product of DC, BITC, bet@ isothiocyanate; BNITC,
/3naphthyl isothiocyanate; ButITC, butyl isothio~yanate; BylITC, butenyl isothiocyanate; CTI, 5,6,ll,l2,17,18-hexahydrocyclononal[l,2-b:4,5-b:7,8-b]triindole cyclic trimer, an acid couden~tion product of 13C, DHII, 5,iO-d~hydroindeno~l,2-~]-indole; DIM, 3,3-diindolylmethane, an acid condensation
product of f3C; I3-, indole-3-; 13A, indole-3-a~tonit~le;
13C, indole-3~arbjnol; 13CHQ indole-3- ~ar~xaldehyde; ICZ, indoIo[3,2-~~arb~ole;
3M1,
3-methylindole; MSPITC, 3-methylsulfinylpropyi isothiocyanate; NCHO, l-met~oxyindole-3~ar~xaIdehyde;
NI3C, I-methoxyindole-3~rbinol;
PBITC,
4-phenylbutyl isothiocyanate; PEITC, Z-phenethyl isothiocyanate; PHITC, 6phenylhexyl isot~io~yanate; PPITC, 3-phenylpropyl isothiocyanate; RXM,
indale-3-carbinol acid reaction mixture (13C with HCI); THII, 4b,5,9b,lO-tetrahydroinde~o[I,~-~]-indol~.
bWhen the testcompound is added before sacrifice, the test system is called in uioo.
T, increased; 1, decreased; +, no effect; 2, greater effect; i.p., intraperitoneal; po., per 0s.
~~thoxyr~oru~n-~-deethyiase,
methoxyresorufin-~-dealkyla~
and ~ntoxyresorufin-~-deethyi~e
activities are principal markers for P450 lA1, P450 lA2
and P450 2B activities, respectively.
eKetoisothiocyanate, ( + )-e~ff-2-a~tyl-6-isothi~yanatonorbomane.
Also 34 other bifu~ctional isothioc~~nates were found to induce NAD(P)H-quinone
redutiase in vitro.

_-..----_

Su~otransfer~e
Superoxide dismutase
UDP glucuronyl transferase

NAD(P)Hquinone
reductase,
also named NABS-qui~one
oxidoreductase, DT-diaphorase

96

D.T.H.

Verhoeven et al. 1 Chemico-Biological Interacrions 103 (3997) 79-129

interesting in vitro systems for identifying compounds with potential chemopreventive activity has been developed by Prochaska and colleagues in the laboratory of
Talalay 1291.This resulted e.g. in the identification of sulforaphane as a hydrolysis
product of glucosinolates [95]. Most data originate from experiments using laboratory animals. There is a limited number of studies dealing with effects of isothiocyanates, indoles and brassicas in man. The results of these studies are presented
separately in Table 8.
Tables 4 and 5 presents the alteration of biotransfo~ation
enzyme activities by
isothiocyanates, indoles and brassicas. In various test systems isothiocyanates,
indoles and brassica vegetables induced both phase 1 enzymes and phase 2 enzymes,
although the induction pattern differs among tissues. Isothiocyanates blocked the
activity of some phase 1 enzymes, depending upon the target tissue and the phase
1 enzyme examined.
Table 6 summarizes the modulation of metabolism and mutagenicity of various
agents by isothiocyanates, indoles and brassicas in different test systems. Isothiocyanates decreased the activation of mutagenic compounds, mostly nitrosamines. In
addition, isothiocyanates reduced the DNA adduct formation induced by 4(methylnitrosamino)- 1-(3-pyridyl)-1 -butanone (NNK) and N-nitrosomethylbenzylamine (NMBA), but not the DNA adduct formation induced by benzo(a)pyrene
(B(a)P) and 2-amino-l-methyl-6-phenylimidazoI4,5-~]pyridine
(PhIP). Indoles were
inhibitors of the DNA-binding of aflatoxin B, (AFB,), B(a)P, PhIP and N-nitrosodimethylamine (NDMA), increased nitrosamine metabolism, and reduced the
number of sister chromatid exchanges induced by mutagens, depending on the kind
of mutagen. Brassica vegetables reduced AFB,-DNA binding.
The in vivo alteration of carcinogenicity of various agents by isot~ocyanates,
indoles and brassica vegetables is presented in Table 7. Both isothiocyanates,
indoles and brassicas reduced tumor formation in miscellaneous tissues, test systems
and using various carcinogenic compounds. When added in vitro to human
erythroleukemic KS62 cells various glucosinolates, viz. sinigrin, gluconapin, progoitrin, epi-progoitrin, sinalbin, glucotropaeolin, glucoerucin, glucocheirolin and
glucoraphenin, had no effect on tumor cell growth [194]. Their hydrolysis-delved
products, produced using myrosinase, showed an inhibition of human erythroleukemic K562 cefl growth, which was most evident for the hydrolysis products,
from sinigrin, glucotropaeolin, glucoerucin and glucocheirolin [ 1941. The hydrolysis-derived products from glucoraphenin decreased the growth of several other
tumor ceils, viz. FL (murine erythroleukemic cells), Jurkat (human T-lymphoid
cells), HeLa (human cervix carcinoma cells), H9 (human T-lymphoid cells) and
H3-TI-1 cells (obtained by transfection of HeLa with a LTR-HIV-l-CAT
plasmid)
[194]. 2-Phenethyl isothiocyanate
(PEITC) and its mercapturic acid pathway
metabolites inhibited the growth of HL60 (human leukaemia 60) cells in vitro. The
adduct with L-cysteine was the most potent inhibitor [195].
Table 8 shows the effects of indoles and brassica vegetables given to hnmans. I3C
induced estradiol 2-hydroxylase, a phase I enzyme. Brassica vegetables, mainly
Brussels sprouts, reduced oxidative DNA damage, increased glutathione S-transferase levels, and induced also estradiol 2-hydroxylase. When 11 smokers ate 56.8

NNK

NNK

NNK

NNK

NNK

NNK

NNK

NNK, NNN

NNK

NNK

NNK

NNK

UO81

1 NNK metabolism, 1 NNN metabolism

[111,112]
]I 121
WI
[I31
[531

1 NNK metabolism
1 NNK metabolism (lung> liver)
---t DNA methylation at .V and 0 of guanine
1 NNK oxidative metabolism

[1101

1 DNA methylation (lung>nasal

1 DNA methylation at O6 of guanine

PO91

1 NNK metabolism
mucosa)

[531

J. NNK oxidative metdbohsm

IlO

[68,106]

[541

1871

11051

Refs

1 Formation of a-hydroxylation products


of NNK
1 NNK oxidative metabolism
1 NNK metabolism (inhibition greater when
pretreated with PEITC)
1 NNK oxidative metabolism

4 Toxicity towards HT29 after detransformation of the ceils

--_

Effect*

indoles, and brassica vegetables


--

In vitro; rat; lung, liver, nasal


mucosa
In vitro; lung (rat, mouse), nasal
mucosa (rat)
In vitro, in vivo (PEITC
prior to NNK or NNN); rat;
oral tissue
In vitro, in vivo (PEITC
prior to NNK); mouse; lung
In vitro, in vivo (PEITC
prior to NNK); mouse (lung);
rat (lung, nasal mucosa)
In vivo; mouse; lung; PEITC
before NNK
In vivo; mouse; lung; pretreatment with PEITC
In vivo: mouse; lung, liver:PEITC
prior to NNK
In vivo; mouse; lung, liver: PETIC
prior to NNK
In vivo; Iung (rat, mouse),
liver and nasal mucosa (rat); pretreatment with PEITC

In vitro; human colorectal


adenocarcinoma cell line
HT29
In vitro; human liver microsomes
In vitro; mouse; lung
In vitro; rat; lung

PEITC

NNK

Test system

Agentb

Compound/
vegetable

Table 6
Modulation of metabolism and mutagenicity of various agents by isothiocyanates,
__
-~-

NNK

PEITC

NMBA

NMBA

NMAA
NMAA

NNK

NNK

NNK

NNK

NNK

Agentb

Compound/
vegetable

Table 6 (continued)

In vivo; rat; esophagus; PEITC


prior to NMBA
In vitro; rat; esophagus

In vivo; rat; lung, nasal mucosa;


PEITC before NNK
In vivo; rat; liver, lung, nasal
mucosa; PEITC before and during
NNK
In vivo; rat; PEITC before and
during NNK
In vivo; rat; lung, liver, pancreas,
kidney, stomach, serum, nasla mucosa; PEITC before and throughout
NNK treatment
In vivo; rat; jejenum; PEITC prior
to NNK
In vivo; rat, monkey; blood, uring;
PEITC prior to NNK
In vitro; rat; liver, esophagus
In vivo; rat; liver, esophagus; pretreatment with PEITC

Test systemc

1 NMBA metabolism,
1 Binding of NMBA metabolites to DNA,
1 DNA methylation at N and O6 of guanine

[I211

WI

P191
[1191

V181

1 NNK metabolic activation


1 NMAA metabolism
1 NMAA metabolism (esophagus > liver),
1 DNA methylation at O6 of guanine not
at N7 (esophagus),
1 DNA methylation at N of guanine not
at O6 (liver)
1 DNA methylation at N and O6 of guanine

ill71

[111,114]

P41

Refs

1 NNK metabolism (in $ less than in 9)

1 Levels of cr-hydroxylation metabolites,


not in nasal mucosa

1 NNK oxidative metabolism

1 DNA methylation at N of guanine in


lung, + liver, + nasal mucosa

1 NNK oxidative metabolism

Effectd

PEIIC

In vitro; DNA repair assays with


E. coli
In vivo; DNA repair assays with
E. coli, in animal mediated asays
with mice

DMN, PhlP

In vitro; micronucleus assays with


Hep-G-2 cells
In vitro (only with PhIP), in vivo
(PEITC before agents); mouse: liver

DMN, PhIP

DMN, PhlP

In vivo; mutagenicity tests


with Salmonella typhimurium;
PEITC-treated mice

DMN, PhIP

DMN, PhIP

WV

W)P

131WWY

In vitro; DNA repair assays with


E. coli; mouse; liver. In vivo; DNA
repair assays with E. cob; mouse;
liver, kidney, lung; PEITC prior to
nitrosamines
In vitro; human bronchial epithehal
cell line
In vivo; mouse; lung; PEITC prior
to B(a)P
In vitro; mouse; lung, liver

NDMA, NDELA,
NPYR (Ref. 124 only
NDMA)

1I271

1 Deactivation pathways of B(a)P metabolism


(PEITC > BITC)
1 Activation of B(a)P-7,8-diol (BITC > PEITC)
1 Genotoxic effects
4 Genotoxic effects of PhIP in liver and colon,
not in stomach and small intestine; 1 genotoxic
effects of DMN in liver, not in gastrointestinal
tracts
PhIP: 1 number of his+ revertants, with liver
homogenate
DMN:J number of his+ revertants, with liver
and kidney homogenates
1 DMN-induced micronuclei; no effect with
PhIP
J. Metabolism of PhIP and DMN

1IW

+ Formation of B(a)P-DNA adducts

[I281

[I281

[I281

[I281

WI

~251

[122-124)

In vitro: 1 DNA-damage in indicator


bacteria
In vivo: J nitrosamine genotoxicity; 1
nitrosamine metabolism (not examined in ref. 124)
-+ B(a)P-DNA binding

NNK
NNK

PITC

PPITC

NNK
NNK

B(a)P

AAF, MAM acetate,


DMBA, DEN
VHlB(c)P

NNK

NNK

NNK
NNK

PhIP

PEITC

BITC

Agentb

Compound/
vegetable

Table 6 (continued)

In vitro; mouse; lung


In vivo; mouse; lung, liver; PPITC
prior to NNK

In vivo; mouse; liver, colon;


PEITC prior to PhIP
In vitro; mouse; lung
In vivo; mouse; lung; PITC
prior to NNK
In vitro; human colorectal
adenocarcinoma cell line
HT29
In vitro; human ovarian carcinoma,
human lung carcinoma, murine
leukemia, murine plasmacytoma
cell line
In vitro; mouse; lung
In vitro; lung (rat, mouse), nasal
mucosa (rat)
In vivo; mouse; lung; BITC prior to
NNK
In vivo; lung (mouse, rat), liver and
nasal mucosa (rat); pretreatment with
BITC
In vivo; rat; liver; pretreatment with
BITC
In vitro; human bronchial epithehal
cell line
In vitro; mouse; lung, liver

Test system

[109]
[531
[111,112]
1531

V301
11251
[1271

1 NNK metabolism
1 NNK metabolism
+ DNA methylation at O6 of guanine
1 NNK metabolism

JUnscheduled and rephcative DNA synthesis


1 B(u)P-DNA binding
1 Deactivation pathways of B(a)P metabolism
(PEITC > BITC)
1 activation of B(a)P-7,Sdiol (BITC > PEITC)
1 NNK metabolism
1 DNA methylation at O6 of guanine in
lung, + liver

11091
11131

6
3.

11291

Cytotoxic effect of BITC to all the cell lines

1 Toxicity towards HT29 after detransformation of the cells

11091
$
[111,1121 8
2
PO51
;
sa
!-

1 NNK metabolism
+ DNA methylation at O6 of guanine

%
2
G!
$
v)

S
~

a
2
5.

jj
3
K
0

W81

+ Formation of DNA adducts

IJ

Refs

Effectd

NNK

NNK
NDMA

AITC

DDITC
Sulforaphane

NMAA

NNK

NNK

NNK
NNK

NNK

NNK

NNK

NNK

NNK
NNK

PPeITC

PHITC

PBITC

typhimurium

In vivo; mouse; liver, lung; PPeITC


prior to NNK
In vitro; human colorectal
adenocarcinoma cell line
HT29
In vitro; mouse; lung
In vitro; Salmonella

In vitro: mouse; lung


In vitro; lung (rat, mouse), nasal
mucosa (rat)
In vitro; lung (rat, mouse), nasal
mucosa (rat)
In vivo; lung (mouse, rat), liver
and nasal mucosa (rat); pretreatment
with PBITC
In vivo; mouse, liver, lung; PBITC
prior to NNK
In vitro; lung (rat, mouse), nasal
mucosa (rat)
In vitro; mouse; lung
In vitro; lung (rat, mouse), nasal
mucosa (rat)
In vivo; mouse; liver, lung; PHITC
prior to NNK
In vivo; lung (rat, mouse), liver and
nasal mucosa (rat); pretreatment
with PHITC
In vivo; rat; liver, esophagus; pretreatment
with PHITC
[106]
[IlO]
[113]

1 NNK oxidative metabolism


1 DNA methylation (lung> nasal mucosa)
1 DNA methylation at O6 of guanine in lung,
-+ liver
1 NNK metabolism

I1311

[lo61
1891

1 NNK oxidative metabolism


1 Mutagenicity of NDMA

(1131

[II91

1 Toxicity towards HT29 after detransformation


of the cells

1 NMAA metabolism (liver > esophagus) 1 DNA


methylation at O6 and N of guanine in liver, +
esophagus
DNA methylation at O6 of guanine

[53]

[53]

11131

1 DNA methylation at O6 of guanine in lung,


-+ liver
1 NNK metabolism

]11]
]531

mucosa)

[lo91
1531

1 NNK metabolism

1 DNA methylation (lung>nasal

j. NNK metabolism
1 NNK metabolism

?
g

g,

$
OS
g
B
;E:

f
g

c,

z
!!?
9

NaN,

NMBA

Sulforaphane

PEITC, BITC,
PPITC, PBITC
I3C

NDMA
NDMA
AFB,

B(a)P, DMN, 2AA,


EMS, DBE

WV

B(a>P

13HlB(a)P

In vitro; mouse; liver

NDMA

Sulforaphane

In vivo; mouse; liver; 13C prior to NDMA


In vivo; mouse; liver; 13C prior to NDMA
In vivo; rainbow trout; liver; I3C prior to
and during AFB,

In vivo; rat; esophagus; testcompounds


prior to NMBA
In vitro; estrogen-responsive and
estrogen-nonresponsive human breast
cancer cells
In vitro; human bronchial epithelial cell
line
In ovo; chick embryo; liver; pretreatment
with 13C
In vivo; mouse; liver; 13C prior to B(a)P
In vitro; chick embryo hepatocytes cocultured with Chinese hamster cells

In vitro; Salmonella
typhimurium

Test systemc

Agentb

Compound/
vegetablea

Table 6 (continued)

1971

f Conversion of B(a)P into water-soluble


metabolites
J B(a)P-DNA binding
1 Number of SCEs induced by B(a)F and
DMN
+ number of SCEs induced by 2AA and
EMS
T number of SCES induced by DBE
1 NDMA-DNA binding
Act as scavenger for reactive electrophiles
1 AFB,-DNA binding

I381
11331
WV341

t37,3gl
t651

[1251

1571

11321

1891

El391

Refs

1 B(u)P-DNA binding

1 DNA methylation at O6 of guanine


(PEITC-PPITC > PBITC > BITC)
JGrowth of estrogen-responsive cells, little
effect on estrogen-nonresponsive cells

J Un~hedul~
DNA synthesis; when
NDMA was not added: unscheduled DNA
synthesis
+ Mutagenicity of NaN,

Effectd

B(a)P, DMN, 2AA,


EMS

B(a)P

13C, I3A

PhIP

PhlP

IQ

CCI,

DMBA

AFB,

AFB,
AFB,

AFB,

AFB,

13A

13c

In vitro; chick embryo hepatocytes cocultured with Chinese hamster cells

In vivo; rat; colon, liver, mammary


gland; 13C prior to and during PhIP
In vitro; chick embryo hepatocytes cocultured with Chinese hamster cells

In vivo; rainbow trout; liver;


I3C prior to and during AFB,
In vivo; rainbow trout; liver;
13C prior to, during and after
AFB,
In vitro; rainbow trout; liver
In vivo; rainbow trout; liver;
13C prior to AFB,
In vivo; rat; liver; 13C prior to
AFB,
In vitro; mouse mammary epithelial
cell line
In vitro, In vivo (13C prior to CCL,);
mouse; liver
In vivo; rat; colon, liver; 13C prior to
and during IQ
In vivo; rat; colon; 13C prior to and
during PhIP; 13C after PhIP; 13C
prior, during and after PhIP

binding

1 Number of SCEs induced by B(a)P;


+number of SCEs induced by DMN, 2AA
and EMS
1 number of SCEs

]I391

[70]

$
6
;
f
a
2.

2.
B
[I381

In vitro: 1 lipid peroxidation


in vivo: protection against hepatotoxicity
1 Number of total aberrant crypts in colon; 1
IQ-DNA adducts in liver
all 3 experiments: 1 aberrant crypt foci 13C
prior, during and after PhIP: t PhIP-DNA
adducts at 6 h, 1 at 24 h and 7 days after PhIP
treatment
1 PhIP-DNA adduct formation

CA

1981

1551

binding

binding

[135,136]

1 DNA repair synthesis

1 AFB,-DNA

+ AFB,-DNA binding
1 AFB,-DNA binding

-+ AFB, metabolism, 1 AFB,-DNA

1 AFB,-DNA

In vivo; rat; liver, lung; testcompounds before AFB,


In ovo; rainbow trout embryo;
coinjection
In vitro; rainbow trout; liver
In vitro; in vivo (testcompounds
before CCL,); rat; liver
In vivo; rat; liver; testcompounds
before agents

AFB,

AFB,

AFB,
ccl,

NNK, NDMA

I3C, RXM

I3C, RXM, DIM

RXM, 01, DIM


I3C, DHII, THII

13C, I3A, indole,


BITC, AITC,
PEITC, PITC,

AFB,

Cabbage

[4451

1 AFB,-DNA

binding

[42]

P431

~421
I.341

11411

i391

WI

Refs

No scavenging of electrophiles
1 AFB,-DNA binding by RXM, not by 13C
J AFB,-DNA binding in lung when given p.o.,
not when given i.p.;
J AFB,-DNA binding by RXM and DIM, not
by 13C
1_AFB, activation and AFB,-DNA binding
In vitro: 1 lipid peroxidation (THII>DHIb~I3C)
in vivo: protection against hepatoxicity (THII >
DHII > 13C)
13C, 13A, indole, BITC: 1 NNK and NDMA
metabolism AITC, PEITC, PITC,
sinigrin: 1 NNK and NDMA metabolism PEITC,
PI-I-C,
sin&in: J, formation of 7-methylguanine and 06methylguanine
1 AFB,-DNA binding only by Brussels sprouts

Effectd

AITC, ally1 isothiocyanate; BITC, benzyl isothiocyanate; CTI, 5,6,1 1,12,17,18-hexahydrocyclononal[l,2-b;4,5-b;7,8-~]tri-indole


cyclic trimer of 13C
DDITC I-dodecyl isothiocyanate; DHII, 5,10-dihydroindeno[l,2-b]-indole;
DIM, 3,3-diindolylmethane, an acid condensation product of 13C; 13A,
indole-3-acetonitrile; 13C, indole-3-carbinol; PBITC, 4-phenylbutyl isothiocyanate; PEITC, 2-phenethyl isothiocyanate; PHITC, 6-phenylhexyl isothiocyanate; PITC, phenyl isothiocyanate; PPeITC, 5-phenylpentyl isothiocyanate; PPITC, 3-phenylpropyl isothiocyanate; RXM, indole-3-carbinol acid reaction
mixture (13C with HCI); THII, 4b,5,9b,lO-tetrahydroindeno[l,Zb]-indole.
b2AA, 2-aminoanthra~ne;
AAF, 2acetylamino~uorene; AFB,, aflatoxin B,; B(a)P, ~nzo(u)pyrene; CCI,, carbon tetradoride DBE dibromoethane DEN,
diethylnitrosamine; DMBA 9,lO-dimethyl-1,2-be~nthr~ne;
DMN, dimethylnitro~mine;
EMS, ethyl methanesulphonate:
IQ, 2-amino-3-methylimidazo]4,5-flquinoline; MAM, methy lazoxymethanol; NaN,, sodium azide; NDELA, N-nitrosodiethanolamine;
NDMA, N-nitrosodimethylamine; NMAA,
N-nitrosomethylamylamine;
NMBA, N-nitrosomethylbenzylamine;
NNK, 4-(N-nitrosome-thylamino)-l-(3-pyfldyl)-t-butanone;
NNN, N-nitrosonornicotine; NPYR, N-nitrosopyrrolidine; PhIP, 2-amino-l-methyl-6-phenylimid~o[4,5-~]pyridine.
When the testcompound is added before sacrifice, the test system is called in vivo.
1, increased; 1, decreased; -+ , no effect; >, greater effect; SCEs, sister ehromatid exchanges; i-p., intra~ritoneal; ~,a., per OS.

AFB,

I3C, Brussels sprouts

In vivo; rat; liver; testcompounds


before AFB,
In vivo; rat; liver; cabbage before
AFB,

In vitro; rainbow trout; liver

AFB,

I3C, RXM

sinigrin

Test system

Agentb

Compound/
vegetablea

Table 6 (continued)

Hamster; PEITC before BOP

Mouse;
DEN

BOP

BOP

DEN
PEITC

before

and aftet

BOP

BGlP
Hamster;
before

Mouse; PEITC prior to and after

B(a)P
PEITC

Mouse; PEITC prior to B(a)P

BW

NMBA

NMBA

NNK

NNK

and multiplicity

1 Incidence and multiplicity


of lung adenomas
and/or adenocarcinomas,
1 pancreatic
tumorigenesis
1 Incidence and multiplicity
of lung and
pancreas tumors,
+ incidence of liver and
renal tumors
1 Yield of foci of altered hepatocytes
and
hepatocellular
adenomas

1 Esophagus
tumor incidence and multiplicity
when given before, during but not following
NMBA
1 Forestomach
tumor multiplicity,
-+ lung, +
skin
+ Lung tumor incidence and multiplicity

incidence

Rat; PEITC prior to and during


NNK treatment
Rat; PEITC prior to and during
NNK treatment
Rat; PEITC before and throughout
NNK reatment
Rat; PEITC prior to, during and
after NMBA
Rat; PEITC after NMBA or before,
during and after NMBA

NNK

tumor

Mouse; PEITC after NNK

NNK

1 Esophageal

1 Lung tumor incidence and multiplicity


1 Lung tumor multiplicity,
+ incidence
A/J mice: 1 lung tumors/mouse,
+ lung tumor
incidence other mice: 1 lung tumor incidence
and multiplicity
-+ % Mouse with lung tumors + no. lung
tumors/mouse
1 Lung tumor incidence,
-+ liver, -+ nasal
cavity
1 Lung tumor incidence, 1 progression
of
benign to malignant
pancreatic
tumors
1 Lung tumorigenesis

Mouse; PEITC prior to NNK


Mouse; PEITC prior to NNK
A/J mice, A/J x TSG-p53FI mice;
PEITC prior to NNK

PEITC

NNK
NNK
NNK

Agentb

Compound/
vegetable

Effect

indoles, and brassica vegetables

Test system

Table I
In vivo modulation of carcinogenicity of various agents by isothiocyanates,

U541

11531

]l521

11261

I1511

ll501

[120,121,132]

11491

Ll51

[111,114]

2
S

31
P
2
S
2

3.
a
!k
0
S
09
g

s!

,:
%
0
5
b
F

[l461
U471

H4gl

5:

[Ill-113,144,145]~

Refs

Rat; PEITC prior to DMBA


Mouse; PEITC together with DMBA

DMBA
DMBA

BITC

PITC

Rat; BITC prior to, during and after


NMBA
Rat; BITC before or after DMBA

Mouse; BITC together with DMBA


Rat, BITC after DMBA
Mouse, BITC after DMH
Mouse; BITC prior to DEN
Rat; BITC before and after DEN
Mouse; BITC together with B(a)P
Mouse; BITC prior to B(a)P
Mouse; BITC prior to B(a)P

NMBA

DMBA

DMBA

DMBA
DMH
DEN

DEN
B(a)P

B(c)P

B(a)P

NNK
NNK

Mouse; PITC prior to NNK


Rat; PEITC prior to DMBA
Mouse; implanted plasmacytoma
subcutaneous tumor; BITC after
implantation
Mouse; BITC prior to NNK
Mouse, BITC after NNK

NNK
DMBA

+ Lung tumor incidence and multiplicity


+ % Mouse with lung tumors
1 no. lung tumors/mouse
+ Esophagus tumor incidence and little
effect on multiplicity
Rat, BITC before DMBA: J mammary
tumor formation rat, BITC after DMBA:
inhibition was diminished
1 Formation of neoplasms of forestomach
and pulmonary adenomas
1 Occurrence of neoplasia of breast
1 Occurrence of neoplasia of large bowel
1 Forestomach tumor formation, --+
pulmonary tumor formation
1 Lung tumor incidence and multiplicity
1 Carcinogenesis of forestomach and lung
(lung > forestomach)
1 Carcinogenesis of forestomach and lung
(lung > forestomach)
1 Lung tumor multiplicity, + forestomach,
+ skin

+ Mammary tumor incidence and multiplicity


1 Mammary tumor formation
1 Formation of neoplasms of forestomach
and pulmonary adenomas
-+ Lung tumor incidence and multiplicity
1 Mammary tumor formation
-+ Tumor mass

Rat; PEITC before and after DMBA

DMBA

PEITC

Effect

Test system

Agentb

Compound/
vegetable

Table 7 (continued)

11511

115g1

[I591
11561

11571
11571
11581

11561

[I561

11321

[111,112,146]
11481

[111,112,146]
]1561
~1291

11561
11561

]1551

Refs

Hamster; PPITC prior to BOP

BOP

Rat; PHITC prior to NMBA


Mouse; PPeITC prior to NNK
Mouse; DDITC prior to NNK
Rat; testcompounds prior to and after
DMBA

NMBA
NNK
NNK
DMBA

PPeITC
DDITC
Sulforaphane, 3
synthetic analogs

NNK
NNK
NNK
NNK

OPBITC
PyBITC
PHITC

AOM

B@P

Mouse; PBITC prior to NNK


Rat; PBITC prior to, during and after
NMBA
Mouse; OPBITC prior to NNK
Mouse; PyBITC prior to NNK
Mouse; PHITC prior to NNK
Rat; PHITC before and throughout
NNK treatment
Mouse; PHITC prior to B(a)P
Rat; PHITC pre-, during and postinitation

NNK
NMBA

PBITC

BOP

Mouse; PPITC prior to NNK


Rat; PPITC prior to, during and after
NMBA
Hamster; PPITC prior to BOP

NNK
NMBA

prior to agents

PPITC

Mouse; testcompounds

B(a)P & NNK

BITC & PEITC

r Skin tumor multiplicity


t Incidence of intestinal adenocarcinomas
and multiplicities of invasive and noninvasive adenocarcinomas of the colon
T Esophagus tumor multiplicity
1 Lung tumor incidence and multiplicity
1 Lung tumor incidence and multiplicity
1 Mammary tumor incidence and multiplicity

--, Lung tumor incidence, 1 lung tumor


multiplicity, 1 stomach tumor incidence
and multiplicity
1 Lung tumor incidence and multiplicity
1 Esophagus tumor incidence and multiplicity
1 Incidence and multiplicity of lung
adenomas and/or adenocarcinomas, +
pancreatic umorigenesis
1 Incidence and multiplicity of lung
adenomas and/or adenocarcinomas; no
modulation of developments of neoplastic
lesions in pancreas, kidney or liver
1 Lung tumor incidence and multiplicity
+ Esophagus tumor incidence and little
effect on multiplicity
-P Lung tumor incidence
+ Lung tumor incidence and multiplicity
J Lung tumor incidence and multiplicity
1 Lung tumorigenesis

[I641
[I131
[IO61
[I651

[I511
[163,52]

[111,146]
[I131
[113,144,162]
U491

[111,113,146]
~321

P611

v521

[111,113,146]
v321

[I@1

Rat; I3C after agents

Rat; 13C before or after DEN

Rat; I3C prior to and after MNIJ


Rat; I3C only during initiation or also
during promotion phase
Rat; testcompounds prior to DMBA

DEN & MNU &


DBN

DEN

MNU
DMBA

DMBA

WN

AFB,
DEN

4NQ0

I3C, DIM, I3A


I3C, DIM, RXM
13C, sin&in

I3C, sinigrin

Mouse; testcompounds prior to B(u)P


In ovo, rainbow trout embryo; coinjection
Rat; testcompounds before, during and
after DEN
Rat, testcompounds before, during and
after 4NQ0, or only after 4NQ0

1 Occurrence of mammary tumors, not


by I3A
1 Occurrence of neoplasms of forestomach
1 Hepat~arcinog~esis
1 Liver tumor incidence and muitiplicity
(sinigrin > 13C)
1 Incidence of tongue neoplasms and of
preneoplastic lesions of the tongue

11671
Wgl

1 Liver tumor incidence


I3C before and during AFB,: 1 hepatocehuiar carcinomas I3C after AFB,: t
hepatic tumor incidence
t Tumorigenesis, f colonic and small
intestinal CanCer incidence
1 Hyperplastic nodules of the liver, 1
lung, + thyroid, -+ kidney, -+ urinary
bladder
13C before DEN: 1 number of GST-Ppositive liver cell foci, 13C after DEN: t
number of and area of GST-P-positivef
liver ceII foci
1 Mammary tumor multiplicity
1 Mammary tumor multipii~ity

AFB,
AFBi, or IEC

[I741

11721
II411
11731

II721

1g21
WI

11711

11701

II691

11361

1 Tumor incidence

Rat; I3C before, during and after DMH

W61

1 Development of papillomas; when I3C


was added to normal cells of the larynx
of mice, it abrogated prohfertive effects of
estradiol
1 Liver tumor incidence
11371

Refs

Effete

to and during

DMH

AFB,
AFB,

AFB,

to, during and

Rainbow trout; I3C prior


after AFB,
Rainbow trout; I3C prior
AFB,
Rainbow trout; I3C after
Rainbow trout; 13C after
before and during AFB,

Mouse; HPV-11 infected laryngeal tissue

Test system

AFB,

Agentb

13C, DIM, I3A

I3C

Compound/
vegetable*

Table 7 (continued)

Rat; cabbage together with AFB,


Mouse; cabbage together with DMH
Rat; cabbage after MNU
Mouse; cabbage before injection with cells

AFB,

AFB,
DMH
MNU
Mammary tumor
cells

Cauliflower

Cabbage
Cabbage
Cabbage
Cabbage

Rat; Brussels sprouts during initiation or


progression period
Rat; cauliflower together with AFB,

DMBA
1 Mammary tumor incidence, when given
during initiation period
Small localii
hepatic tumors instead of
very large ones & metastasis when treated
only with AFB,
1 No. of tumors/liver
1 Tumor frequency
1 Incidence of mammal cancer
1 No. of pulmonary metastases

1 Mammary tumor formation

WI

WY

I1781
1179)

[361

I1771

(175,176)

aBITC, benzyl isothiocyanate; DDITC, I-dodecyl isothiocyanate; DIM, 3,3-diindolylmethane, an acid condensation product of 13C; I3A, indole-3-acetonitrile; 13C, indole-3-carbinol; OPBITC, oxopyridylbutyl isothiocyanate; PBITC, phenylbutyl isothiocyanate; PEITC, 2-phenethyl isothiocyanate; PHITC,
~phenylhexyl isothiocyanate; PITC, phenyl isothio~yanate; PPeITC, S-phenylpentyl isothiocyanate; PPITC, 3-phe~yl~ropy1 isothiocyanate; PyBITC,
4-(3-pyridyl)butyl isothiocyanate; RXM, indole-3-carbinol acid reaction mixture (I3C with HCI).
bAFB,, aflatoxin B,; AOM, azoxymethane; B(a)P, benzo(u)pyrene; BOP, N-nitrosobis(2-oxopropyl)amine;
DBN, NJ-dibutyl
nitrosamine; DEN, N-t&
tro~d~ethylamine; DMBA, 7,12dimethy~~nz(u)anthra~ne;
DMH, symmetri~ai l,Z-dimethylhydrazine dihydr~hloride;
MNU, ~-methylnitrosoure~;
NMBA, ~-nitrosomethyl~nzylamine;
NNK, 4-(N-nitrosome-thylamino)-l-(3-pyridyl)-l-butanone;
4NQ0, 4-njtroquinol~ne l-oxide.
5, increased; 1, decreased; -t , no effect; no., number; >, greater effect.
dAlso isothiocyanates with larger alkyd chain length or secondary isothioeyanates showed to reduce tumor incidence and multiplicity (secondary>primary,
larger chain >shorter chain).
3 analogs are ego-2-acetyl-ego-6-isothiocyanatonorbo~ane,
e~~o-2-acetyi-e~~-6-isothi~yanatonorbomane
ego-2-a~tyl-e~o~5-isothi~yanatonorbornane,
GST-P, ~lutathione 5-transferase placental form.

Rat, vegetables after DMBA

DMBA

Cabbage,
cauliflower,
broccoli
Brussels sprouts

;;
tw
2
8
,u
;;:

ij
2,
$

Y
g
@_
W

110

D.T.N. Verhoeven et ai. / Chemico-BiologicalInferactions 103 (1997) 79-129

g watercress, a eruciferous vegetable, at each meal for 3 days, an increase in the


urinary excretion of detoxification metabolites of NNK was found [196]. In a study
of Caporaso et al. [SS], no inhibition of P450 2D6 activity was found in males and
females after consumption of 50 g watercress. When PEITC, a constituent of
watercress, was added in vitro to human liver microsomes, an inhibition of P450
2D6 activity was shown [88].
4.3. ~~scuss~o~ on anticarc~nogen~c action
Isothiocyanates, indoles and brassica vegetables have been shown to modulate
phase 1 and phase 2 enzyme activities. The induction of phase 1 enzymes can result
in inhibition of activation of compounds, but also in bioactivation of compounds.
When phase 2 enzymes are induced besides phase 1 enzymes, the activated
compounds can be detoxified.
Yu et al. [197] suggest that c-Jun N-terminal kinase 1 (JNKI) is involved in the
regulation of phase 2 detoxifying enzyme gene expression. When added to human
ovarian HeLa cells in vitro, PEITC caused a sustained activation of JNKl. Phenyl
isothiocyanate, phenylmethyl isothiocyanate,
Sphenylpentyl
isothiocyanate and
6-phenylhexyl isothiocyanate were weak inducers of JNKl activity, whereas 3phenylpropyl isothiocyanate and 4-phenylbutyl isothiocyanate stimulated transient
activation [ 1971.
Indoles, unlike isothiocyanates, induce the phase I enzyme estradioi 2-hydroxylase. This leads to the biotransformation of estradiol to 2-hydroxyestrone which has
a minimal estrogenic activity [61]. Liu et al. 1781showed that induction of estradiol
meta~lism was not required for the antiestro~nic activity of 13C and indoIq3,2blcarbazole (ICZ). In this study ICZ was also found to be a weak estrogen which
binds to the estrogen receptor. Jongen et al. [97] have found that modulating effects
of indoles are not directly related to induction of phase 1 enzymes, but to a shift in
the balance between phase 1 and phase 2 enzymes in favour of phase 2 enzymes.
The anticarcinogenic actions of the glucosinolate hydrolysis products and brassicas depend on the experimental conditions. Of importance are among others the
test system and the target tissue. It was shown that different test systems produced
different results and the modulation of enzyme activities, mutagenicity and carcinogenicity of compounds differed among tissues. Also of importance is the kind of
carcinogenic/mutagenic
agent that is used. Isothiocyanates were inhibitors of the
activation and DNA-binding of ~-nitrosamines, but seemed to have no effect on
the formation of ~nzo(a)pyrene-DNA
adducts.
The time interval between uptake of the anticarcinogenic compound and carcinogen exposure is also of importance for inhibition of tumor formation. Inhibition
would only occur when this time interval is short [122,123,144,156]. Preinitiation
exposure to indoles seems to reduce the carcinogen challenge, but postinitiation
exposure seems to enhance the effect of carcinogens f167,168].
Furthe~ore,
the anticarcinogenic action depends on the kind of anticarcinogenic
compound. In a recent study of Jiao et al. [106], it was found that the isothiocyanate functional group is essential for the inhibitory effects of isothiocyanates in

11841
U851

t2-Hydroxy-estrone:estriol
ratio
1 Levels of I-oxodG (oxidative DNA
damage)
1 Plasma GST-a levels
1 Plasma half-life of antipyrine,
t metabolic clearance rate of antipyrine
1 phenacetin plasma concentration,
+ plasma half-life of phenacetin
7 Plasma GST-a levels in males,
+ plasma GST-n levels
+ GST activity,
r rectal GST-a and -x levels
t 2-Hydroxyestrone/l6a-hydroxyestrone
ratio
+ 6-hydroxychlorzoxazone: chlorzoxazoneratio (P450 2El not affected);
7 caffeine metabolic ratio (P450 IA2 affected); f2-hydroxyestrone/l6a-hydroxyestrone ratio
t P450 IA2 activity, + IV-acetyltransferase
and xanthine oxidase activity
Males
Males &
females

Males &
females
Males &
females
Females
Males &
females

Males &
females

300 g per day for 3 weeks


300 g and 200 g respectively per
day for 7 days

300 g per day for 7 days

300 g per day for 7 days

380-400 g per day for 5 days

500 g per day for 12 days

500 g per day for IO days

Brussels sprouts
Brussels sprouts & cabbage

Brussels sprouts

Brussels sprouts

Mix of Brussels sprouts, cabbage,


broccoli and cauliflower
Broccoli

Broccoli

13C, indole-3-carbinol.
bT, increased; 1. decreased; + , no effect; GST. Glutathione-S-transferase;

I3C
Brussels sprouts

R-oxodG, 8-oxo-7,8-dihydro-2-deoxyguanosine.

[I831

t Estradiol 2-hydroxylation

Males &
females
Females
Males

[192,193]

u911

u901

11891

[1881

[1861
[If371

11821

r Estradiol 2-hydroxylation

Males

500 mg (6-7 mg/kg) per day for


I week
500 mg (6-7 mg/kg) per day for
1 week
400 mg per day for 3 months
300 g per day for 3 weeks

I3C

I3C

Refs

Effectb

Subjects

Dose and duration

Compound/vegetable

Table 8
Effects of indoles and brassicd vegetables given to humans

NNK-induced lung tumori~enes~s. In experiments using various arylalkyl isothiocyanates, i.e. isothio~yanates with an aromatic side chain like PEITC, it was found
that the inhibitory activity of these isothiocyanates against tumorigenesis was
increased with alkyl chain length [53,109--113,146). It is suggested that isothiocyanates can bind to the active sites of certain phase 1 enzymes which is governed
largely by lipophilicity and results in competitive inhibition or covalent inactivation
of these enzymes [145]. Although the difference in inhibitory activity is accurate
with respect to NNK car~inogenesis in A/J mouse lung, it is not found for NMBA
car~inogenesis in the rat esophagus. PEXTC was found to be a potent inhibitor of
NMBA ~~c~nogenesis in the rat esophagus ]120,121], but the longer chain isothiocyanate, 4-phe~ylbu~yl isothio~yanate (PB~TC~, was found to be less effective than
PEITC [132], and 4-phe~ylhexyl isot~oc~anate (PHITC) actually enhanced NMBA
t~origenesis
in the rat esophagus [164]. In addition, PHITC enhanced
a~oxymethane carcinogenesis in the rat colon ]52].
Most studies on indoles examined the anticarcinogenic effect of 13C. Some
studies also examined the effect of synthetic indole compounds or acid condensation products of 13C. It is concluded that synthetic indole compounds seem to have
a greater potential as chemoprotective agents than 13C, because of an observed
dose-dependent intrinsic toxicity of 13C [34,35]. Besides, the in vivo effects of 13C
may be attributed to indole acid condensation products, such as DIM and XCZ, but
not to 13C itself [62,64,71,75,76,141,198]. The formation of acid ~~densation
products in the stomach is a likely prerequisite for I3C anticarcinogen~is.
ICZ is
also the most important product of ascorbigen ~ransfo~ation
in gastric juice.
Some of the cancer-modulating activities of ascorbigen may be due to IGZ 1191.
In comparison to the number of studies using indoles and isothio~yanates the
number of studies using whole brassica vegetables is small. The anticarcinogenic
effects of the individual compounds may be different from the effect of brassicas,
because of possible interactions between compounds of the vegetables. The animal
studies on brassicas were carried out with freeze-dried or cooked vegetables.
Human studies were carried out with lightly steamed or cooked vegetables. Processing vegetables leads to a certain degree of glucosinolate hydrolysis by myrosinase
hydrolysis or other chemical reactions. By cooking the vegetables myrosi~se is
inactivated and loss of intact glu~sinolates occurs because of thermal degradation
and wash out 1181, In studies using whole bras&a vegetables, it was found that
these vegetables affected phase I and phase 2 enzyme activities, decreased AFBlDNA binding and decreased tumor formation.
Most evidence concerning anticar~inogenic effects of glucosinolate hydrolysis
products and brassica vegetables results from in vivo studies in animals. In animal
studies differences between species are found which makes it difficult to extrapolate
the results to humans. Schulze et al. [199] found differences between species in both
the extent of total metabolism of NNK (hamsters > mice > rats) and the metabolite
composition. The dose of both the anticarcinogenic and the carcinogenic compound
used in animal studies is usually much higher than those to which man is exposed
via a normal diet. In a study of Kore et al. f32] no signi~~~t induction of phase
I and phase 2 enzymes were detected when 3-metb~lsul~~ylpropyl isothiocy~ate

was tested at doses approximate to those found in human diet. However, isothiocyanates, indoles and brassicas may have beneficial effects. At high but realistic
consumption levels, indoles and brassicas did show positive effects on health in
human studies [182- 1911. This seems to be in accordance with epidemiological
studies that showed a negative association between consumption of brassica vegetables and cancer risk [200].

5. Adverse effects of glucosinolate hydrolysis products and brassicas


The putative beneficial properties of glucosinolate hydrolysis products and
brassicas are the main focus of this review. Beside beneficial effects, brassicas,
glucosinolates and their hydrolysis products have also shown some adverse effects.
Therefore, their possible mutagenicity, carcinogenicity, toxicity and goitrogenicity
are described in short.
5.1. Possible mutagenicity and carcinogenicity

Besides anticarcinogenic properties a few isothiocyanates and indoles showed


mutagenic and carcinogenic properties in some studies (Table 9). According to
McDanell et al. [17] a possible hazard from indoles is an ability to react with
nitrites to form carcinogenic 1V-nitroso compounds. Tiedink et al. 12061found that
brassica vegetables contain precursors of N-nitroso compounds, but that glucosinolates and indole compounds should not be considered as important precursors of
directly mutagenic N-nitroso compounds in brassicas [212,213]. 13A, when tested
pure, formed directly mutagenic N-nitroso compounds upon nitrite treatment,
while in green cabbage it contributed only marginally to the total mutagenicity of
the nitrite treated cabbage [212].
5.2. Toxicity

In various studies the toxicity of glucosinolates and their hydrolysis products are
described. In a study of Morse et al. PEITC and benzyl isothiocya~te
(BITC)
decreased food consumption and body weight gain in mice [14X]. In rats, BITC
caused a decrease in food consumption and body weight gain, an increase in serum
cholesterol level, renal dysfunction and changes in weights of various organs [214].
In mice, 5, IO-dihydroindenol[ l,Zb]indole (a synthetic indole) produced no observable 24 h acute toxicity, but I3C elicited hepatotoxicity, demonstrated by increases
in plasma alanine aminotransferase and ornithine transcarbamylase activities, and
13C produced increases in neurological impairment [35]. In a study of Nishie and
Daxenbichler [215] the toxicological effects of epiprogoitrin, sinigrin and sinalbin
(cruciferous glucosinolates) and nine of their derivatives (isothiocyanates, nitriles,
R-Svinyl-2-oxazolidinethione)
were examined in the rat. None of the compounds
proved teratogenic, but ally1 isothiocyanate, 3-methylsulfinylpropyl isothiocyanate
and 1-cyano-3,4-epithiobutane
were embryotoxic. High intake of rapeseed glucosi-

vitro

Ascorbigen
I-~ethyI~rbigen
Cauliflower, Brussels sprouts, cabbage,
broccoli, kohlrabi, Swede

TAlOO
TAlOO
TAIOO
TA98, TAlOO
TAIOO
TA98, TAlOO,

AITC, BITC, sinigrin


AITC, BITC, MITC, PEITC
AITC
AITC
Sulforaphane
I3C, 13A, 13-acetamide, 13-acetic acid,
3-methyhndole,
13-akdehyde, 13-carboxyhc acid, indole
WP2 uvrA/pKMlOi &
treated with nitrite at
PH 3
TA98, TAlOO
TA98, TAlOO
TAlOO

Strain?

indoles, and cruciferae

Substratea

Gene mutations in bacteria (Ames test)

1. In

Table 9
Mutagenicity and carcinogenicity of isothiocyanates,

-act

Results

-+
+

-+
3

+d

-+

+ act

PO51
PW
PO61

~1241
PO21
12031
WI
w41

PO11

Ref

uvrB/recA, uvr+/rec+

AITC, BITC, MITC, PEITC

AITC

Substrate

-..-~-

Chinese hamster epithelial cells


Human fibroblasts

Test system

----

. _.. .._

.._--_-... .

Chinese hamster ovary cells


Chinese hamster ovary cells
Chinese hamster epithelial cells
Indian muntjac cells
Human hepatma cells
Indian muntjac cells
Indian muntjac cells

Sinigrin, gluconasturtin
BITC
AITC
AITC, BITC, PEITC, PITC
AITC, EITC, PEITC, MITC
Ascorbigen
I-methylascorbigen

._

Chinese hamster ovary cells

AITC, PEITC

Neoplastic transformation of cultured mammalian cells

Chinese hamster ovary cells

-_^_I_____~

Test systems

AITC, BITC, PEITC

Substratea

Chromosome mutations in cultured mammalian cells

Strainsb

Substratea

DNA repair in bacteria

by AITC

SCEs

SCEs, nor

SCEs, not

--~-

. ._~

Neoplastic transformation
No neoplastic transformation

Results, -cat

-+ CA and SCEs
-+ CA, t SCEs at highly
cytotoxic doses

1 CA and
by AITC
f CA and
by AITC
t CA
t CA and
T CA
7 CA, not

-act

-act

_-

TMN

T CA

+ act

+ act

[IlO]

WfI

P-051

w41

w91

Wgl
12031

w71

12071

11241

Ref

~1241

Ref

_--.-.

--

T Transitional-cell papillomas of the


urinary bladder in male rats only
No tumor induction
1 Mammary tumor incidence and
multiplicity
I Incidence of endometrial and uterine adenocarcinoma, I Incidence of
mammary fibroadenoma, 1
Frequency of preneoplastic endometrial lesions

2 year assay, rat


2 year assay, mouse
8 months assay, mouse
660 days assay, rat

AITC

13C

13c

Ref

AITC, ally1 isothiocyanate; BITC, benzyl isothiocyanate; 13-, indole-3-; 13A, indole-3-acetonitrile; I3C, indole-3-carbinol; MITC, methyl isothiocyanate;
PEITC, phenetbyl isothiocyanate; PITC, phenyl isothiocyanate.
bSaimonella typ~~murium strains TA98, TABOO;Es~herichja coli WP2 uvrA/pKMlOl, uvrB/recA, uvr+jrec+.
-act, without metabolic activation; fact, with metabolic activation; + , positive; -, negative, -+, no effect; 1, increased; 1, decreased.
dhigh concentration of metabofising system suppressed mutagenicity.
addition of metabohsing system reduced effect.
after treatment with nitrite under acid conditions.
GA, chromosome aberrations; SCEs, sister chromatid exchanges; MN, micronucleus.

ResuhsC

.--.

Test system

vivo

Substratea

2. In

Table 9 (continued)

nolates or their hydrolysis products resulted in growth decrease [216] and liver
enlargement 12171 in animals. When a rapeseed glucosinolate~rich diet was fed to
growing rats liver and kidneys weights increased, and feed intake and growth curve
depleted [ZIS]. When rats were fed diets with a high content of Brussels sprouts,
growth depression and decreased food intake, decreased haemoglobin levels, increased prothrombin times, and an increase in relative kidney and liver weight
occurred [l-5]. No toxic effects were found when humans were given a diet with a
high but realistic content of Brussels sprouts 12193.
From these studies it can be concluded that consumption of glucosinoIates and
their hydrolysis products can result in toxic effects. However, no toxic effects on
humans have been identified so far and the doses used in the animal studies exceed
the normal human daily consumption by far.
5.3. Goitrogenicity
Brassica vegetables have a goitrogenic potential [7,17]. The goitrogenic effects
have been ascribed to hydrolysis products of glucosinolates, in particular thiocyanate ion and 5-vinyloxazolidine-2~thione
(goitrin). The mechanism of goitrogenicity seems to be different between thiocyanate ion and goitrin. The thiocyanate
ion would compete with iodine for uptake by the thyroid gland. Thus, its goitrogenicity depends upon the iodine content of the diet. Coitrin would interfere with
thyroid hormone synthesis and would therefore be goitrogenic irrespective of the
iodine status.
In several studies goitrogenicity of rapeseed glucosinolates was examined [2 171. In
animals, inhibition of thyroid hormone synthesis, thyroid hy~rtrophy
and goitre
occurred, depending upon the dose of rapeseed glucosinolates tested and the
animals used. In swine, reacting strongly to the goitrogenic activity of rapeseed
glucosinolates [217], this is particularly a problem since rapeseed contributes largely
to their food intake. Feeding a diet with a high content of Brussels sprouts to rats
resulted in decreased levels of circulating thyroxin and in an increase of morphological thyroid activation [15]. In human, no effect of a high but realistic intake of
Brussels sprouts on the thyroid function was found [219,220].

There is now much evidence to suggest that brassica vegetables possess anticarcinogenic properties. Components of brassicas possibly responsible for these properties are glucosinolates. Myrosinase-catalysed
transfo~ation
of glucosinolates
seems necessary for the anticarcinogenic effects, thereby releasing isothiocyanates
or indoles as the active principles. Isothiocyanates and indoles influence several
processes related to chemical carcinogenesis, e.g. the activity of phase 1 and phase
2 biotransformation
enzymes, and the metabolism, DNA-binding and mutagenic
activity of promutagens. Hence, a possible inhibitory activity of isothiocyanates and
indoles against tumo~genesis appears to stem mainly from their ability to influence

118

D.T.H.

Verhoeven et al. / Chemico-Biological Interactions IO3 (1997) 79-129

phase 1 and phase 2 biotransformation enzyme activities. It should be emphasized


that their protective action seems to depend upon many factors, such as the test
system, the target tissue, the type of carcinogen challenge and anticarcinogenic
compound, the doses, as well as the timing of the treatment. In contrast to their
presumed protective action, some isothiocyanates showed mutagenic potential in
mammalian cells and bacteria.
Most evidence concerning anticarcinogenic effects of glucosinolate hydrolysis
products and brassica vegetables has come from studies in animals. Because of
inter-species differences, and since the dose of both the anticarcinogenic and the
carcinogenic compound used in animal studies often greatly exceeds the estimated
level of the compound in a normal human diet, it is difficult to extrapolate results
from animal studies to humans. Therefore, more studies are required in which
normal consumption levels are used to find out whether the glucosinolate hydrolysis
products and brassica vegetables also exert their protective effects in humans.
Besides examining the effects of the individual compounds, studies should examine
the effects of glucosinolates and their hydrolysis products in their normal matrix,
because of possible interactions between vegetable compounds.

Acknowledgements

The authors thank J. Bogaards for his comments on this manuscript.

References
[1] K.A. Steinmetz and J.D. Potter, Vegetables, fruit, and cancer. I. Epidemiology, Cancer Causes
Control, 2 (1991) 3255357.
[2] G. Block, B. Patterson and A. Subar, Fruit, vegetables, and cancer prevention: a review of the
epidemiological evidence, Nutr. Cancer, 18 (1992) I-29.
[3] G. Hocman, Prevention of cancer: vegetables and plants, Comp. Biochem. Physiol., 93B (1989)
201-212.
[4] K.A. Steinmetz and J.D. Potter, Vegetables, fruit, and cancer. II. Mechanisms, Cancer Causes
Control, 2 (1991) 427744
[5] L.O. Dragsted, M. Strube and J.C. Larsen, Cancer-protective factors in fruits and vegetables:
biochemical and biological background, Pharmacol. Toxicol., 72 Suppl 1 (1993) 116-135.
[6] L.W. Wattenberg, Inhibition of carcinogenesis by minor dietary constituents, Cancer Res., 52
(1992) 2085s-2091s.
[7] G.R. Fenwick, R.K. Heany and W.J. Mullin, Glucosinolates and their breakdown products in
food and food plants. CRC Crit. Rev. Food Sci. Nutr., 18 (1983) 1233201.
[S] S. Sasaki, Inhibitory effects by a-naphthyl-isothiocyanate
on development of hepatonoma in rats
treated with 3-methyl-4-dimethyl-aminoazobenzene,
J. Nara. Med. Assoc., 14 (1963) lOl- 115.
[9] H. Sidransky, N. Ito and E. Verney, Influence of a-naphthyl-isothiocyanate
on liver tumorigenesis
in rats ingesting ethionine and N-2-fluorenylacetamide, J. Nat. Cancer Inst., 37 (1966) 677-686.
[lo] G.R. Fenwick and R.K. Heany, Glucosinolates and their breakdown products in cruciferous
crops, foods and feedingstuffs, Food Chem., 11 (1983) 2499271.
[ll] Ministry of Agriculture Fisheries and Food, National Food Survey 1992. Annual report on
household food consumption and expenditure, HMSO, London, 1993.

[12] C. Kistemaker, E.J.M. Aarnink and K.F.A.M. Hulshof, De consumptie van afzonderlijke produk-

ten door Nederlandse bevolkingsgroepen. Voedselconsumptiepeiling 1992, TNO, Zeist, 1993.


fl3] K. Sones, R.K. Heany and G.R. Fenwick, An estimate of the mean daily intake of glucosinolates
from cruciferous vegetables in the UK, J. Sci. Food Agric., 35 (1984) 712-720.
[14] B.A. Slominski and L.D. Campbell, Formation of indole glucosinolate breakdown products in
autolyzed, steamed, and cooked Brassica vegetables, J. Agric. Food Chem., 37 (1989) 1297- 1307.
[15] A.P. de Groot, MI. Willems and R.H. de Vos, Effects of high levels of Brussels sprouts in the diet
of rats, Food Chem. Toxicol., 29 (1991) 829-837.
[16] K. Sones, R.K. Heany and G.R. Fenwick, Glucosinolates in Bramica vegetables. Analysis of
twenty-seven cauliflower cultivars (Brassicu oleracea L. var. botryris subvar. cauliftora DC), _I.Sci.
Food Agric., 35 (1984) 762-766.
[17] R. McDanell and A.E.M. McLean, Chemical and biological properties of indole glucosinolates
(glucobrassicins): a review, Food Chem. Toxicol., 26 (1988) 59970.
[IS] R.H. de Vos and W.G.H. Blijleven, The effect of processing conditions on glucosinolates in
cruciferous vegetables, Z. Lebensm. Unters. Forsch.. 187 (1988) 525-529.
1191 M.N. Preobrazhenskaya, V.M. Bukhman, A.M. Korolev and S.A. Efimov, Ascorbigen and other
indole-derived compounds from Brassica vegetables and their analogs as anticarcinogenic and
immunomodulating agents, Pharmacol. Ther., 60 (1993) 301-313.
[20] D.I. McGregor, W.J. Mullin and G.R. Fenwick, Review of analysis of glucosinolates: analytical
methodology for determining glucosinolate composition and content, J. Assoc. Off. Anal. Chem.,
66 (1983) 825--549.
[21] CC. Harris, Chemical and physical carcinogenesis: advances and perspectives for the 1990s.
Cancer Res., 51 (1991) 5023s-5044s.
[22] S. de Flora, A. Izzotti and C. Bennicelli, Mechanisms of antimutagenesis and anticarcinogenesis:
role in primary prevention. in: G. Bronzetti, H. Hayatsu, S. de Flora. M.D. Waters and D.M.
Shankel (Eds}, Antimutagenesis and anticarcinogenesis mechanisms 111,Plenum Press, New York,
1993, pp. l---16.
[23] W.B. Jakoby, Enzymatic basis of detoxification, Vol I and 11, Academic press, London, 1980.
{24] Nordic Council of Ministers, Naturally occurring antitumourigens. II Organic isothiocyanates,
TemaNord, Copenhagen, 1994.
[25] C. Boone, G.J. Kelloff and W.E. Malone, Identification of candidate cancer chemopreventive
agents and their evaluation in animal models and human clinical trials: a review, Cancer Res., 50
(1990) 2-9.
[26] Y. Zhang and P. Talalay, Anticarcinogenic activities of organic isothiocyanates: chemistry and
mechanisms, Cancer Res., 54 (1994) 1976~s1981s.
[27] D.L. Davis, H.L. Bradlow, M. Wolff, T. Woodruff, D.G. Hoel and H. Anton-Culver, Medical
hypothesis: xeno-estrogens as preventable causes of breast cancer, Environ. Health Perspect., 101
(1993) 372-377.
[28] E.B. Thorling, Dietary non-nutritive cancer protective factors, Eur. J. Cancer Prev., 2 (1993)
95 103.
[29] H.J. Prochaska, A.B. Santamaria and P. Talalay, Rapid detection of inducers of enzymes that
protect against carcinogens. Proc. Natl. Acad. Sci., 89 (1992) 2394-2398.
[30] K.O. Lindros, T, Badger, M. Ronis, M. Ingelman-Sundberg and M. Koivusalo, Phenethyl
isothiocyanate, a new dietary liver aldehyde dehydrogenase inhibitor, J. Pharmacol. Exp. Ther.,
275 (1995) 79-83.
[31] B. Ozierenski, R. Plass and H.-J. Lewerenz, Effects of glucosinolate breakdown products on the
hepatic biotransformation system in male rats, Nahrung, 37 (1993) 5-14.
[32] A.M. Kore, E.H. Jeffery and M.A. Wallig, Effects of I-isothiocyanato-3-(methylsulfinyl)-propane
on xenobiotic metabolizing enzymes in rats, Food Chem. Toxicol., 31 (1991) 7233729.
[33] H.G. Shertzer, Indole-3-carbinol and indole-3-acetonitrile
influence on hepdtic microsomal
metabolism, Toxicol. Appi. Pharmacol., 64 (1982) 3533361.
[34] H.G. Shertzer and M. Sainsbury, Chemoprotective and hepatic enzyme induction properties of
indole and indenoindole antioxidants in rats, Food Chem. Toxicol., 29 (1991) 391-400.

120

D.T.H.

Verhoeuen et al. J ~hemico-Biological

~nteraciio~s 103 (1997) 79-129

I351 H.G. Shertzer and M. Sainsbury, Intrinsic acute toxicity and hepatic enzyme inducing properties
of the chemoprotectants indole-3-carbinol and 5,lO-dihydroindeno[l,2-6]indole
in mice, Food
Chem. Toxicol., 29 (1991) 237-242.
[361 G.S. Stoewsand, J.B. Babish and H.C. Wimberly, Inhibition of hepatic toxicities from polybrominated biphenyls and adatoxin B, in rats fed cauliflower, J. Environ. Pathol. Toxicol., 2 (1978)
399-406.
r.371H.G. Shertzer, Protection by indole-3-carbinol against covalent binding of benzo[u]pyrene metabolites to mouse liver DNA and protein, Food Chem. Toxicol., 21 (1983) 31-35.
[381 H.G. Shertzer, Indole-3-carbinol protects against covalent binding of benzo[a]pyrene and N-nitrosodimethylamine metabolites to mouse liver macromolecules, Chem. Biol. Interact., 48 (1984)
81-90.
[391 J.-Y. Park and L.F. Bjeldanes, Organ-selective induction of cytochrome P-4.50-dependent activities
by indole-3~rbinol-derived
products: influence on covalent binding of benzo[~]pyrene to hepatic
and pulmonary DNA in the rat, Chem. Biol. Interact., 83 (1992) 235-247.
[401 W.D. Loub, L.W. Wattenberg and D.W. Davis, Aryl hydrocarbon hydroxylase induction in rat
tissues by naturally occurring indoles of cruciferous plants, 1. Natl. Cancer Inst., 54 (1975)
985-988.
[411 CA. Bradfield and L.F. Bjeldanes, Effect of dietary indole-3-carbinol on intestinal and hepatic
monooxygenase, glutathione S-transferase and epoxide hydrolase activities in the rat, Food Chem.
Toxicol., 22 (1984) 977-982.
[421 A.D. Salbe and L.F. Bjeldanes, Effect of diet and route of administration on the DNA binding of
aflatoxin B, in the rat, Carcinogenesis, IO (1989) 629-634.
L431A.D. Salbe and L.F. Bjeldanes, The effects of dietary Brussels sprouts and Schizundru chinensis on
the xenobiotic-metabolizing enzymes of the rat small intestine, Food Chem. Toxicol., 23 (1985)
57-65.
WI S. Hendrich and L.F. BjeIdanes, Effects of dietary cabbage, Brussels sprouts, Ill~~ium serum,
Schizandra ch~~e~~~~and alfalfa on the ~nzo[alpyrene
metabolic system in mouse liver, Food
Chem, Toxicol., 21 (1983) 479-486.
1451J.P. Whitty and L.F. Bjeldanes, The effects of dietary cabbage on xenobiotic-metabolizing enzymes
and the binding of aflatoxin B, to hepatic DNA in rats, Food Chem. Toxicol., 25 (1987) 581-587.
[461 K.E. Aspry and L.F. Bjeldanes, Effects of dietary broccoli and butylated hydroxanisole on
liver-mediated metabolism of benzo[a]pyrene, Food Chem. Toxicol., 21 (1983) 133- 142.
[471 E.J. Pantuck, K.-C. Hsiao, W.D. Loub, L.W. Wattenberg, R. Kuntzman and A.H. Conney,
Stimulatory effect of vegetables on intestinal drug metabolism in the rat, J. Pharmacol. Exp. Ther.,
198 (1976) 278-283.
[481 L.W. Wattenberg, Studies of polycyclic hydrocarbon hydroxylases of the intestine possibly related
to cancer. Effect of diet on benzpyrene hydroxylase activity, Cancer, 28 (1971) 99- 102.
induced
I491 T.B. Leonard, J.A. Popp, M.E. Graichen and J.G. Dent, r-Naphthylisothiocyanate
alterations in hepatic drug metabolizing enzymes and liver morphology: implications concerning
anticarcinogenes~s, Carcinogenesis, 2 (1981) 473-482.
[501 T.B. Leonard, J.A. Popp, M.E. Graichen and J.G. Dent, ~-Naphthylisothiocyanate-induced
alterations in hepatic drug metabolism and liver morphology, Toxicol. Appl. Pharmacol., 60
~_~
(1981) 527-534.
1511T.A. Eisele, G.S. Bailey and J.E. Nixon, The effect of indole-3-carbinol, an aflatoxin B,
hepatocarcinoma inhibitor, and other indole analogs on the rainbow trout hepatic mixed function
oxidase system, Toxicol. Lett., I9 (1983) 133-138.
[S2] C.V. Rao, A. Rivenson, B. Simi, E. Zang, R. Hamid, G.J. Kelloff, V. Steele and B.S. Reddy,
Enhancement of experimental colon carcinogenesis by dietary 6phenyihexyl isothiocyanate,
Cancer Res., 55 (1995) 4311-4318.
[53] Z. Guo, T.J. Smith, E. Wang, K.I. Eklind, F.-L. Chung and C.S. Yang, Structure-activity
relationships of arylalkyl isothiocyanates for the inhibition of 4-(methylnitrosamino)-I -(3-pyridyl)I-butanone metabolism and the modulation of xenobiotic-meta~li~ng
enzymes in rats and mice,
Carcinogenesis, 14 (1993) 1167- 1173.

D.T.H.

Verhoeven et al. / Chemico-Biological Interactions 103 (1997) 79-129

[54] Z. Guo, T.J. Smith, E. Wang, N. Sadrieh, Q. Ma, P.E. Thomas

I21

and C.S. Yang, Effects of


phenethyl isothiocyanate, a carcinogenesis inhibitor, on xenobiotic-metabolizing
enzymes and
nitrosamine metabolism in rats, Carcinogenesis, I3 (1992) 2205-22 IO.
[55] A. Suto, H.L. Bradlow, G.Y.C. Wong, M.P. Osborne and N.T. Telang, Experimental down-regulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells, Breast
Cancer Res. Treat., 27 (1993) 193-202.
[56] A. Suto, H.L. Bradlow, G.Y. Wong, M.P. Osborne and N.T. Telang, Persistent estrogen
responsiveness of ras oncogene-transformed mouse mammary epithelial cells, Steroids, 57 (1992)
2622268.
[57] R.K. Tiwari, L. Guo, H.L. Bradlow, N.T. Telang and M.P. Osborne, Selective responsiveness of
human breast cancer cells to indole-3-carbinol, a chemopreventive agent, J. Nat]. Cancer Inst., 86
(1994) 126-131.
[58] T. Niwa, G. Swaneck and H.L. Bradlow, Alterations in estradiol metabolism in MCF-7 cells
induced by treatment with indole-3-carbinol and related compounds, Steroids, 59 (1994) 5233527.
[59] T. Kojima. T. Tanaka and H. Mon, Chemoprevention of spontaneous endometrial cancer in
female Donryu rats by dietary indole-3-carbinol, Cancer Res., 54 (1994) 1446- 1449.
[60] W.S. Baldwin and G.A. Le Blanc, The anti-carcinogenic plant compound indole-3-carbinol
differentially modulates P450-mediated steroid hydroxylase activities in mice, Chem. Biol. Interact., 83 (1992) 1555169.
[61] H.L. Bradlow, J.J. Michnovicz, N.T. Telang and M.P. Osborne, Effects of dietary indole-3carbinol on estradiol metabolism and spontaneous mammary tumors in mice, Carcinogenesis, 12
(1991) 157lIl574.
[62] P.H. Jellinck, P.G. Forkert, D.S. Riddick, A.B. Okey, J.J. Michnovicz and H.L. Bradlow, Ah
receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation.
Biochem. Pharmacol., 45 (1993) 112991136.
[63] D.W. Sepkovic, H.L. Bradlow, J.J. Michnovicz, S. Murtezani, I. Levy and M.P. Osborne,
Catechol estrogen production in rat microsomes after treatment with indole-3-carbinol, ascorbigen, or /I-naphthaflavone: a comparison of stable isotope dilution gas chromatography-mass
spectrometry and radiomettic methods, Steroids, 59 (I 994) 3 I8 -323.
[64] A.T. Fong, HI. Swanson, R.H. Dashwood, D.E. Williams, J.D. Hendricks and G.S. Bailey,
Mechanisms of anti-carcinogenesis by indole-3-carbinol: studies of enzyme induction, electrophilescavenging, and inhibition of aflatoxin B, activation. Biochem. Pharmacol., 39 (1990)
19-26.
[65] W.M.F. Jongen, R.J. Topp, K.J.H. Wienk, and E.C. Homan, Modulating effects of naturally
occurring indoles on SCE induction depend largely on the type of mutagen, Mutat. Res., 222
(1989) 263-269.
[66] H. Ishizaki. J.F. Brady, S.M. Ning and C.S. Yang, Effect of phenethyl isothiocyanate on
microsomal N-nitrosodimethylamine metabolism and other monooxygenase activities, Xenobiotica, 20 (1990) 255-264.
[67] N. Takahashi, R.H. Dashwood, L.F. Bjeldanes, G.S. Bailey and D.E. Williams, Regulation of
hepatic cytochrome P450lA by indole-3-carbinol: transient induction with continuous feeding in
rainbow trout, Food Chem. Toxicol., 33 (1995) I I l-120.
[68] T.J. Smith. Z. Guo, C. Li, S.M. Ning, P.E. Thomas and C.S. Yang, Mechanisms of inhibition of
4-(methylnitrosamino)-I-(3-pyridyl)-I-butanone
bioactivation in mouse by dietary phenethyl isothiocyanate, Cancer Res., 53 (1993) 327663282.
[69] N. Takahashi, D.M. Stresser, D.E. Williams and G.S. Bailey, Induction of hepatic CYPIA by
indole-3-carbinol in protection against aflatoxin B, hepatocarcinogenesis in rainbow trout. Food
Chem. Toxicol., 33 (1995) 841-850.
[70] M. Xu, A.C. Bailey, J.F. Hernaez, C.R. Taoka, H.A.J. Schut and R.H. Dashwood, Protection by
green tea, black tea, and indole-3-carbinol against 2-amino-3-methylimidazo[4,57f]quinoline-induced DNA adducts and colonic aberrant crypts in the F344 rat, Carcinogenesis, I7 (1996)
1429- 1434.
[7l] H.M. Wortelboer, E.C.M. van der Linden, C.A. de Kruif, J. Noordhoek, B.J. Blaauboer, P.J. van
Bladeren and H.E. Falke, Effects of indole-3-carbinol on biotransformation enzymes in the rat: in

122

D.T.H. Yerhoeven et al. j ~hern~~o-Biological Interaction

103 (1997) 79-129

uivo changes in liver and small intestinal mucosa in comparison with primary hepatocyte cultures,
Food Chem. Toxicol., 30 (1992) 589-599.
[72] I. Chen, S. Safe and L. Bjeldanes, Indole-3-carbinol and dundolylmethane as aryl hydrocarbon
(Ah) receptor agonists and antagonists in T47D human breast cancer celis, Biochem. Pharmacol.,
51 (1996) 1069-1076.
[73] R.E. McDanell, A.E.M. McLean, A.B. Hanley, R.K. Heany and G.R. Fenwick, Differential
induction of mixed-function oxidase (MFO) activity in rat liver and intestine by diets containing
processed cabbage: correlation with cabbage levels of glucosinolates and glucosinolate hydrolysis
products, Food Chem. Toxicol., 25 (1987) 363-368.
[74] H.M. Wortelboer, CA. de Kruif, A.A.J. van Iersel, H.E. Falke, J. Noordhoek and B.J. Blaauboer,
Acid reaction products of indole-3-carbinol and their effects on cytochrome P450 and phase II
enzymes in rat and monkey hepatocytes, Biochem. Pharmacol., 43 (1992) 143991447.
1751C.A. Bradfield and L.F. Bjeldanes, Structure-activity relationships of dietary indoles: a proposed
mechanism of action as modifiers of xenobiotic metabolism, J. Toxicol. Environ. Health, 21 (1987)
311-323.
[76] L.F. Bjeldanes, J.-Y. Kim, K.R. Grose, J.C. Bartholomew and C.A. Bradfield, Aromatic hydrocarbon responsiveness-receptor
agonists generated from indole-3-carbinol in vitro and in vivo:
comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin,
Proc. Natl. Acad. Sci. USA, 88 (1991)
9543-9547.
[77] Y.H. Chen, J. Riby, P. Srivastava, J. Bartholomew, M. Denison, and L. Bjeldanes, Regulation of
CYPlAl by indolo[3,2-t,]carbazole in murine hepatoma cells, J. Biol. Chem., 270 (1995) 22548
22555.
[78] H. Liu, M. Wormke, S.H. Safe and L.F. Bjeldanes, Indolo[3,2-b]carbazoie: a dietary-derived
factor that exhibits both antiestrogenic and estrogenic activity, J. Natl. Cancer Inst., 86 (1994)
1758-1765..
[79] R. McDaneli, A.E.M. McLean, A.B. Hanley, R.K. Heaney and G.R. Fenwick, The effect of
feeding brassica vegetables and intact glucosinoIates on mix~-function-oxidase
activity in the
livers and intestines of rats, Food Chem. Toxicol., 27 (1989) 289-293.
[SO] H.M. Wortelboer, CA. de Kruif, A.A.J. van Iersel, J. Noordhoek, B.J. Blaauboer, P.J. van
Bladeren and HE. Falke, Effects of cooked Brussels sprouts on cytochrome P-450 profile and
phase I],+enzymes in liver and small intestinal mucosa of the rat, Food Chem. Toxicol., 30 (1992)
17-27.
[81] D.M. Stresser, G.S. Bailey and D.E. Williams, Indole-3-carbinol and P-naphthoflavone induction
of aflatoxin B, metabolism and cytochromes P-450 associated with bioactivation and detoxification of atlatoxin B, in the rat, Drug Metab. Dispos., 22 (1994) 383-391.
[82] C.J. Grubbs, V.E. Steele, T. Casebolt, M.M. Juliana, I. Eto, L.M. Whitaker, K.H. Dragnev, G.J.
Kelloff and R.L. Lubet, Chemoprevention of chemically-induced mammary carcinogenesis by
indole-3-carbinol, Anticancer Res., 15 (1995) 709-716.
(831 0. Vang, M.B. Jensen and H. Autrup, Induction of cytochrome P4SOIAl in rat colon and liver
by indole-3~rbinol
and 5,6-~nzoflavone, Carcinogenesis, 11 (1990) 1259- 1263.
[84] P.H. Jellinck, A.-M. Newcombe, P.G. Forkert and C.P. Martucci, Distinct forms of hepatic
androgen 6+&-hydroxylase induced in the rat by indole-3~arbinol and pregnenolone carbonitrile, J.
Steroid B&hem. Molec. Biol., 51 (1994) 219-225.
[SS] 0. Vang, H. Jensen and H. Autrup, Induction of cytochrome P-4501A1, IA2, IIBl, IIB2 and HE1
by broccoli in rat liver and colon, Chem. Biol. Interact., 78 (1991) 85-96.
[86] T.J. Smith, 2. Guo, F.P. Guengerich and C.S. Yang, Metabolism of 4-(methylnitrosamino)-l-(3pyridyl)-1-butanone (NNK) by human cytochrome P450 lA2 and inhibition by phenethyl isothiocyanate (PEITC), Proc. Am. Assoc. Cancer Res., 36 (1995) 153.
[87] T.J. Smith, Z. Guo, F.P. Guengerich and C.S. Yang, Metabolism of 4-(methylnitrosamino)-l-(3pyridyl)-1-butanone (NNK) by human cytochrome P450 lA2 and its inhibition by phenethyl
isothiocyanate, Carcinogenesis, 17 (1996) 809-813.
[88] N. Caporaso, J. Whitehouse, S. Monkman, C. Boustead, H. Issaq, S. Fox, M.A. Morse, J.R. Idle
and F.-L. Chung, In vitro but not in viuo inhibition of CYP2D6 by phenethyl isothiocyanate
(PEITC), a constituent of watercress, Pha~acog~etics,
4 (1994) 275-280.

D.T.H.

Verhoeven et al. / Chemico-Biological Interactions 103 (1997) 79-129

[89] S. Barcelo, J.M. Gardiner,

123

A. Gescher and J.K. Chipman, CYP2EImediated


mechanism of
anti-genotoxicity of the broccoli constituent sulforaphane, Carcinogenesis, 17 (1996) 277-282.
[90] E.M.M. Van Lieshout, W.H.M. Peters and J.B.M.J. Jansen, Effect of oltipraz, a-tocopherol,
p-carotene and phenethylisothiocyanate
on rat oesophageal, gastric, colonic and hepatic glutathione, glutathione S-transferase and peroxidase, Carcinogenesis, 17 (1996) 1439- 1445.
[91] V.L. Sparnins and L.W. Wattenberg, Enhancement of glutathione S-transferase activity of the
mouse forestomach by inhibitors of benzo(a]pyrene-induced neoplasia of the forestomach, J. Natl.
Cancer Inst., 66 (1981) 769-771.
[92] V.L. Spamins, J. Chuan and L.W. Wattenberg, Enhancement of glutathione S-transferase activity
of the esophagus by phenols, lactones, and benzyl isothiocyanate, Cancer Res., 42 (1982)
120551207.
[93] V.L. Spamins, P.L. Venegas and L.W. Wattenberg, Glutathione S-transferase activity: enhancement by compounds inhibiting chemical carcinogenesis and by dietary constituents, J. Natl.
Cancer Inst., 68 (1982) 493-496.
[94] A.M. Benson and P.B. Barretto, Effects of disulfiram, diethyldithiocarbamate, bisethylxanthogen,
and benzyl isothiocyanate on glutathione transferase activities in mouse organs, Cancer Res., 45
(1985) 4219-4223.
[95] Y. Zhang, P. Talalay, C-G. Cho and G.H. Posner, A major inducer of anticarcinogenic protective
enzymes from broccoli: isolation and elucidation of structure, Proc. Natl. Acad. Sci. USA, 89
(1992) 2399-2403.
[96] J.J.P. Bogaards, B. van Ommen, H.E. Falke, M.I. Willems and P.J. van Bladeren, Glutathione
S-transferase subunit induction patterns of Brussels sprouts, ally1 isothiocyanate and goitrin in rat
liver and small intestinal mucosa: a new approach for the identification of inducing xenobiotics,
Food Chem. Toxicol., 28 (1990) 81-88.
[97] W.M.F. Jongen, R.J. Topp, P.J. van Bladeren, J. Lapre, K.J.H. Wienk and R. Leenen, Modulating effects of indoles on benzo[a]pyrene-induced sister chromatid exchanges and the balance
between drug-metabolizing enzymes, Toxic. in vitro, 3 (1989) 2077213.
[98] D.M. Stresser, D.E. Williams, L.I. McLellan, T.M. Harris and G.S. Bailey, Indole-3-carbinol
induces a rat liver glutathione transferase subunit (Yc2) with high activity toward aflatoxin
B,exo-epoxide: association with reduced levels of hepatic aflatoxin-DNA adducts in viva. Drug
Metab. Dispos., 22 (1994) 392-399.
[99] W.A. Nijhoff, G.M. Groen and W.H.M. Peters, Induction of rat hepatic and intestinal glutathione
S-transferases and gluthathione by dietary naturally occurring anticarcinogens, Int. J. Oncol.. 3
(1993) 1131ll139.
[IOO] S. Rabot, L. Nugon-Baudon and 0. Szylit, Alterations of the hepatic xenobiotic-metabolizing
enzymes by a glucosinolate-rich diet in germ-free rats: influence of a pre-induction with phenobarbital, Br. J. Nutr., 70 (1993) 347-354.
[loll A.M. Benson, P.B. Barrett0 and J.S. Stanley, Induction of DT-diaphorase by anticarcinogenic
sulfur compounds in mice, J. Natl. Cancer Inst., 76 (1986) 467-473.
[102] G.H. Posner, C.-G. Cho, J.V. Green, Y. Zhang and P. Talalay, Design and synthesis of
bifunctional isothiocyanate analogs of sulforaphane: correlation between structure and potency as
inducers of anticarcinogenic detoxification enzymes, J. Med. Chem., 37 (1994) 170- 176.
[103] N. Tawhq, R.K. Heaney, J.A. Plumb, G.R. Fenwick, S.R.R. Musk and G. Williamson, Dietary
glucosinolates as blocking agents against carcinogenesis: glucosinolate breakdown products assessed by induction of quinone reductase activity in murine hepalclc7 cells, Carcinogenesis, 16
(1995) 1191-1194.
[104] G. Williamson, Effects of food components on phase 1 (activating), phase 2 (conjugating) and
antioxidant enzymes, in: H. Kozlowska, J. FomaI and Z. Zduticzyk (Eds.), Proc. of the Int.
Conference Euro Food Tox IV Bioactive substances in food of plant origin, Vol. 2 Dietary
Cancer Prevention, Centre for Agrotechnology and Veterinary Sciences, Olszytn, Poland 1994, pp.
360-370.
[IO51 S.R.R. Musk, P. Stephenson, T.K. Smith, P. Stening, D. Fyfe and I.T. Johnson, Selective toxicity
of compounds naturally present in food toward the transformed phenotype of human colorectal
cell line HT29, Nutr. Cancer, 24 (1995) 289-298.

124

D.T.H.

Verhoeven et al. / Chemico-Biological Interactions 103 (1997) 79-129

[IO61 D. Jiao, T.J. Smith, S. Kim, C.S. Yang, D. Desai, S Amin and F.-L. Chung, The essential role of

the functional group in alkyl isothiocyanates for inhibition of tobacco nitrosamine-induced lung
tumorigenesis, Carcinogenesis, 17 (1996) 755-759.
(1071 K. Doerr-ORourke, N. Trushin, S.S. Hecht and G.D. Stoner, Effect of phenethyl isothiocyanate
on the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-I-(3-pyridyl)-l-butanone by cultured rat lung tissue, Carcinogenesis, 12 (1991) 102991034.
[IO81 SE. Murphy, R. Heiblum, P.G. King, D. Bowman, W.J. Davis and G.D. Stoner, Effect of
phenethyl isothiocyanate on the metabolism of tobacco-specific nitrosamines by cultured rat oral
tissue, Carcinogenesis, 12 (1991) 957-961.
[109] T.J. Smith, Z. Guo, P.E. Thomas, F.-L. Chung, M.A. Morse, K.I. Elkind, and C.S. Yang,
Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-l-butanone
in mouse lung microsomes and its
inhibition by isothiocyanates, Cancer Res., 50 (1990) 6817-6822.
[I IO] Z. Guo, T.J. Smith, P.E. Thomas and C.S. Yang, Metabolic activation of 4-(methylnitrosamino)I-(3-pyridyl)-I-butanone
as measured by DNA alkylation in vitro and its inhibition by isothiocyanates, Cancer Res., 51 (1991) 479884803.
[I I I] M.A. Morse, K.I. Ekhnd, S.S. Hecht and F.-L. Chung, Inhibition of tobacco-specific nitrosamine
4-(N-nitrosomethylamino)-l-(3-pyridyl)-l-butanone
(NNK) tumorigenesis with aromatic isothiocyanates, IARC Sci. Publ., 105 (1991) 529-534.
[I 121 M.A. Morse, S.G. Amin, S.S. Hecht and F.-L. Chung, Effects of aromatic isothiocyanates on
tumorigenicity, 06-methylguanine formation, and metabolism of the tobacco-specific nitrosamine
4-(methylnitrosamino)-I-(3-pyridyl)-I-butdnone
in A/J mouse lung, Cancer Res., 49 (1989) 28942897.
[I131 M.A. Morse, K.I. Eklind, S.S. Hecht, K.G. Jordan, C-I. Choi, D.H. Desai, S.G. Amin, and F.L.
Chung, Structure-activity relationships for inhibition of 4-(methylnitrosamino)-I-(3-pyridyl)-l-butanone lung tumorigenesis by arylalkyl isothiocyanates in A/J mice, Cancer Res., 51 (1991)
1846-1850.
[I 141 M.A. Morse, C.-X. Wang, G.D. Stoner, S. Mandal, P.B. Conran, S.G. Amin, S.S. Hecht, and
F.-L. Chung, Inhibition of 4-(methylnitrosdmino)-I-(3-pyridyl)-l-butanone-induced
DNA adduct
formation and tumorigenicity in the lung of F344 rats by dietary phenethyl isothiocyanate, Cancer
Res., 49 (1989) 5499553.
[I151 S.S. Hecht, N. Trushin, J. Rigotty, S.G. Carmella, A. Borukhova, S. Akerkar and A. Rivenson,
Complete inhibition of 4-(methylnitrosamino)-I-(3-pyridyl)-l-butanone-induced
rat lung tumorigenesis and favorable modification of biomarkers by phenethyl isothiocyanate, Cancer Epidemiol.
Biomarkers Prev., 5 (1996) 645-652.
[116] M.E. Staretz and S.S. Hecht, Effects of phenethyl isothiocyanate on the tissue distribution of
4-(methylnitrosamino)-I -(3-pyridyl)-I -butanone and metabohtes in F344 rats, Cancer Res., 55
(1995) 5580-5588.
[117] J. Schulze, A. Malone and E. Richter, Intestinal metabolism of 4-(methylnitrosamino)-1-(3pyridyl)-l-butanone in rats: sex-difference, inducibility and inhibition by phenethylisothiocyanate,
Carcinogenesis, 16 (1995) 173331740.
[118] S.S. Hecht, N. Trushin, S.G. Carmella, S. Akerkar, J. Rigotty and L.M. Anderson, Inhibition of
4-(methylnitrosamino)-I-(3-pyridyl)-I-butanone
metabolic activation by phenethyl isothiocyanate
in rats and primates as assessed by biomarkers, Proc. Am. Assoc. Cancer Res., 36 (1995) 593.
[119] Q. Huang, T.A. Lawson, F.-L. Chung, C.R. Morris and S.S. Mervish, Inhibition by phenylethyl
and phenylhexyl isothiocyanate of metabolism of and DNA methylation by N-nitrosomethylamylamine in rats, Carcinogenesis, 14 (1993) 7499754.
[120] M.A. Morse, H. Zu, A.J. Galati, C.J. Schmidt and G.D. Stoner, Dose-related inhibition by dietary
phenethyl isothiocyanate of esophageal tumorigenesis and DNA methylation induced by N-nitrosomethylbenzylamine in rats, Cancer Lett., 72 (1993) 103-I IO.
[121] G.D. Stoner, D.T. Morrissey, Y.-H. Heur, E.M. Daniel, A.J. Galati and S.A. Wagner, Inhibitory
effects of phenethyl isothiocyanate on N-nitrosobenzylmethylamine
carcinogenesis in the rat
esophagus, Cancer Res., 51 (1991) 2063-2068.
[122] S. Knasmiiller, W.W. Huber, H. Kienzl and R. Schulte-Hennann,
Inhibition of repairable
DNA-damage in Escherichiu cob K-12 cells recovered from various organs of nitrosamine-treated

D.T.H.

Verhoeven et al. / ~he~~~o-3~oIo~i~al Interactions fO3 (1997) 79-129

125

mice by vitamin A, phenethylisothiocyanate,


oleic acid and triolein, Carcinogenesis, 13 (1992)
1643- 1650.
[I231 S. Knasmiiller, W.W. Huber and R. Schulte-Hermann, Prevention of genotoxic effects by dietary
constituents in various organs of mice treated with nitrosamines, Basic Life Sci., 61 (1993)
441-451.
[I241 K. Fekadu, S. Musk, W. Parzefall, I. Johnson, G. Sontag, R. Schuite-Hermann, R. and S.
Knasmiiiler, Antigenotoxic and genotoxic effects of naturally occurring isothiocyanates (ITCs), in:
H. Kozlowska, J. Fornal and 2. Zduhczyk (Eds.), Proc. of the Int. Conference Euro Food Tox IV
Bioactive substances in food of plant origin, Vol 2 Dietary Cancer Prevention, Centre for
Agrotechnology and Veterinary Sciences, Olszytn, Poland, 1994, pp. 501-507.
[I251 S. Sharma, J.D. Stutzman, G.J. Kelloff and V.E. Steele, Screening of potential chemopreventive
agents using biochemical markers of carcinogenesis, Cancer Res., 54 (1994) 5848-5855.
[i26] G. Adam-Rodweli, MA. Morse and G.D. Stoner, The effects of phenethyi isothiocyanate on
~n~o[~]pyrene-indu~
tumors and DNA adducts in A/J mouse lung, Cancer Lett., 71 (1993)
35-42.
11271 M.E. Staretz, L.A. Koenig and S.S. Hecht, Effects of isothi~yanates
on ~nzo[a]pyrene
metabolism by mouse lung and liver microsomes, Proc. Am. Assoc. Cancer Res.. 36 (1995) 593.
11281S. Knasmtiiier, M.D. Friesen, J.A. Holme, J. Alexander. R. Sanyai, F. Kassie and H. Bartsch,
Effects of phenethyl isothio~yanate on metabolism and on genotoxicity of dimethylnitrosamin~
and 2-amino-l-methy~-6-phenylimid~o[4,5-~]pyridine
(PhIP), Mutat. Res., 350 (1996).
[129] A.M. Pintao, M.S.S. Pais, H. Coiey, L.R. Keiland and 1.R. Judson, In vitro and in vivo antitumor
activity of benzyl isothiocyanate: a natural product from ~~0~~~0~~~2rnuj~s. Planta Med.. 61
(1995) 233-236.
[130] S. Sugie, N. Yoshimi, A. Okumura, T. Tanaka and H. Mon, Modifying effects of benzyi
isothiocyanate and benzyl thiocydnate on DNA synthesis in primary cultures of rat hepatocytes,
Carcinogenesis, 14 (1993) 281-283.
[I311 S.R.R. Musk and LT. Johnson, Ally] isothiocyanate is selectively toxic to transformed ceils of the
human colorectai tumour line HT29, Carcinogenesis. 14 (1993) 2079-2083.
11321J.T. Wilkinson, M.A. Morse, L.A. Kresty and G.D. Stoner, Effect of alkyl chain length on
inhibition of N-nitrosomethylbenzylamine-induced
esophageal tumorigenesis and DNA methylation by isothiocyanates, Carcinogenesis, 16 (1995) loll- 1015.
[I331 H.G. Shertzer and M.W. Tabor, Nucleophilic index value: implication in the protection by
indoie-3-carbinol from N-nitrosodimethylamine
cyto and genotoxicity in mouse liver, J. Appl.
Toxicol., 8 (1988) 105-110.
[134] D.E. Goeger, D.W. Shelton, J.D. Hendricks and G.S. Bailey, Mechanisms of anticarcinogenesis by
indole-3-carbinoi: effect on the distribution and metabolism of aflatoxin B, in rainbow trout,
Carcinogenesis, 7 (1986) 2025-2031.
[I351 R.H. Dashwood, D.N. Arbogast, A.T. Fong, J.D. Hendricks and G.S. Bailey, Mechanisms of
anti-carcinogenesis by indoie-3-carbinol: detailed in viw DNA binding dose-response studies after
dietary administration with aflatoxin Bl, Carcinogenesis, 9 (1988) 427-432.
[136] R.H. Dashwood, D.N. Arbogast, A.T. Fong, C. Pereira, J.D. Hendricks, and G.S. Bailey.
Q~ntitative inter-relationships between aflatoxin Bi carcinogen dose, indole-3~arbinol anti-carcinogen dose, target organ DNA adduction and final tumor response, ~~rcinogenesis. 10 (1989)
175-181.
[137] J.E. Nixon, J.D. Hendricks, N.E. Pawlowski, C.B. Pereira, R.O. Sinnhuber and G.S. Bailey,
Inhibition of aflatoxin B, carcinogenesis in rainbow trout by flavone and indoie compounds,
Carcinogenesis, 5 (1984) 615-619.
[138] H.G. Shertzer, M.L. Berger and M.W. Tabor, Intervention in free radical mediated hepatotoxicity
and lipid ~roxidation by indole-3-carbinoi, Biochem. Pharmacoi., 37 (1988) 333-338
[139] D. Guo, H.A.J. Schut, C.D. Davis, E.G. Snyderwine, G.S. Bailey and R.H. Dashwood, Protection
by chiorophyilin and indole-3~arbinol against 2-amino-i -methyl-6-phenyiimid~o[4,5-&]py~dine
(PhlP)-induced DNA adducts and colonic aberrant crypts in the F344 rat, Carcinogenesis, 16
(1995) 2931-2937.

126

D.T.H.

Verhoeuen et al. / Chemico-Biological Interaciions IO3 (1997) 79-129

[I401 H.A.J. Schut and R.H. Dashwood,

Inhibition of DNA adduct formation of 2-amino-I-methyl-6phenylimidazo[4,5-~]pyridine (PhIP) by dietary indole-3-carbinol (13C) in the mammary gland,
colon, and liver of the female F-344 rat, Ann. N.Y. Acad. Sci., 768 (1996) 210-214.
[141] R.H. Dashwood, A.T. Fong, D.N. Arbogast, L.F. Bjeldanes, J.D. Hendricks and G.S. Bailey,
Anti~rcinogeni~ activity of indole-3~arbinol acid products: ultrasensitive bioassay by trout
embryo microinjection, Cancer Res., 54 (1994) 361773619.
11421N. Takahashi, R.H. Dashwood, L.F. Bjeldanes, D.E. Williams and G.S. Bailey, M~hanisms of
indole-3-c~binol (13C) anti~rcinogenesis: inhibition of aflatoxin B,-DNA adduction and mutagenesis by I3C acid condensation products, Food Chem. Toxicol., 33 (1995) 851-857.
I1431 F.-L. Chung, M. Wang and S.S Hecht, Effects of dietary indoles and isothiocyanates on
~-nitrosodimethylamine
and 4-{methylnitrosoamino)-l-(3-pyridyl)-1-bu~none
a-hydroxylation
and DNA methylation in rat liver, Carcinogenesis, 6 (1985) 539-543.
[144] M.A. Morse, K.I. Eklind, S.G. Amin and F.-L. Chung, Effect of frequency of isothiocyanate
administration
on inhibition of 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone-induced
pulmonary adenoma formation in A/J mice, Cancer Lett.. 62 (1992) 77-81.
[145] D. Jiao, K.I. Eklind, C.-l. Choi, D.H. Desai, S.G. Amin and F.-L. Chung, Structure-activity
relationships of isothiocyanates as mechanism-based inhibitors of 4-(methylnitrosamino)-l-(3pyridyl)-1-butatone-induced
lung tumorigenesis in A/J mice, Cancer Res., 54 (1994) 4327-4333.
[146] M.A. Morse, K.I. Eklind, S.G. Amin, S.S. Hecht and F.-L. Chung, Effects of alkyl chain length
on the inhibition of NNK-induced lung neoplasia in A/J mice by arylalkyl isothiocyanates,
Carcinogenesis, 10 (1989) 1757-1759.
[I471 S.A. Matzinger, K.A. Crist, G.D. Stoner, M.A. Anderson, M.A. Pereira, V.E. Steele, G.J. Kelloff,
R.A. Lubet and M. You, K-ras mutations in lung tumors from NJ and NJ X TSG-p53 F, mice
treated with 4-(methylnitrosamino)-I-(3-pyridyl)-1-butanone
and phenethyl isothiocyanate, Carcinogenesis, 16 (1995) 2487-2492.
[148] M.A. Morse, J.C. Reinhardt, S.G. Amin, S.S. Hecht, G.D. Stoner and F.-L. Chung, Effect of
dietary aromatic isothiocyanates fed subsequent to the administration of 4-(methylnitrosamino)- l(3-pyridyl)-I-butanone on lung tumorigenicity in mice, Cancer Lett., 49 (1990) 225-230.
11491 F.-L. Chung, G. Kelloff, V. Steele, B. Pittman, E. Zang, D. Jiao, J. Rigotty, C.-I. Choi and A.
Rivenson, Chemopreventive efficacy of arylalkyl isothiocyanates and N-acetylcysteine for lung
tumorigenesis in Fischer rats, Cancer Res., 56 (1996) 772-778.
[150] J.C. Siglin, D.H. Barth and G.D. Stoner, Effects of dietary phenethyl isothiocyanate, ellagic acid,
sulindac and calcium on the induction and progression of ~-nitrosomethyl~nzylamineinduced
esophageal carcinogenesis in rats, Carcinogenesis, 16 (1995) 1IOI- 1106.
[ISI] J.-M. Lin, S.G. Amin, N. Trushin and S.S. Hecht, Effects of isothi~yanates on tumo~genesis by
benzo[aJpyrene in murine tumor models, Cancer Lett., 74 (1993) 151- 159.
[152] A. Nishikawa, F.-L. Chung, F. Furukawa, T. Imazawa, S. Ikezaki, M. Takahashi and Y. Hayashi,
Chemopreventive effects of phenethyl and 3-phenylpropyl isothiocyanates on lung and pancreatic
carcinogenesis initiated with .~-nitrosobis(Z-oxopropyl)amine
in hamsters, Proc. Am. Assoc.
Cancer Res., 36 (1995)126.
[153] A. Nishikawa, F. Furukawa, C. Uneyama, S. Ikezaki, Z. Tanakamaru, F.-L. Chung, M.
Takahashi and Y. Hayashi, Chemopreventive effects of phenethyl isothiocyanate on lung and
pancreatic tumorigenesis in N-nitrosobis(2-oxopropyl)amine-treated
hamsters, Carcinogenesis, 17
(1996) 1381-1384.
11541 M.A. Pereira, Chemoprevention of diethylnitrosamine-induced
liver foci and hepatocellular adenomas in C3H mice, Anticancer Res., 15 (1995) 1953-1956.
[I551 V.E. Steele, R.A. Lubet, G.J. Kelloffl, I. Eto, L.M. Whitaker and C.J. Grubbs, Chemopreventive
efficacy of miconazole (MCZ), anethole trithione (ATT), phenethyl isothiocyanate (PEITC), and
N-acetyl-L-cysteine (NAC) in the DMBA-induced rat mammary tumor model, Proc. Am. Assoc.
Cancer Res., 36 (1995) 590.
[156] L.W. Wattenberg, Inhibition of carcinogenic effects of polycyclic hydrocarbons by benzyl isothiocyanate and related compounds, J. Natl. Cancer Inst., 58 (1977) 395-398.
[I 571 L.W. Wattenberg, Inhibition of carcinogen-induced neoplasia by sodium cyanate, tert-butyl
isothiocyanate, and benzyl isothiocyanate administered subsequent to carcinogen exposure, Cancer
Res., 41 (1981) 2991-2994.

D.T.H. Verhoeven et al. 1 Chemico-Biological Interactions 103 jf997) 79-129

127

[158] L.W. Wattenberg, Inhibitory effects of benzyl isothiocyanate administered shortly before diethylnitrosamine or benzo[a]pyrene on pulmonary and forestomach neoplasia in A/J mice, Carcinogenesis, 8 (1987) 1971-1973.
[I591 S. Sugie, A. Okumura, T. Tanaka and H. Mon, Inhibitory effects of benzyl isothiocyanate and
benzyl thiocyanate on diethylnitrosamine-induced
hepatocarcinogenesis in rats, Jpn. J. Cancer
Res., 84 (1993) 865-870.
[160] S.S. Hecht, S. Isaacs and N. Trushin, Lung tumor induction in A/J mice by the tobacco smoke
carcinogens 4-(methylnitrosamino)-I-(3-pyridyl)-I-butanone
and benzo[a]pyrene: a potentially useful model for evaluation of chemopreventive agents, Carcinogenesis, 15 (1994) 2721-2725.
[I611 A. Nishikawa, F. Furukawa, S. Ikezaki, Z. Tanakamaru, F.-L. Chung, M. Takahashi and Y.
Hayashi, Chemopreventive effects of 3-phenylpropyl isothiocyanate on hamster lung tumorigenesis
initiated with N-nitrosobis(2-oxopropyl)amine,
Jpn. J. Cancer Res., 87 (1996) 122- 126.
[162] W.L. Alworth, R. Young-Sciame and S.S. Hecht, Inhibition of 4-(methylnitrosamino)-l-(3pyridyl)-1-butanone mouse lung tumorigenesis by arylalkynes, mechanism-based inactivators of
cytochrome P450, Carcinogenesis, 14 (1993) 1711-1713.
[I631 C.V. Rao, A. Rivenson, B. Simi, R. Hamid, E. Zang and B.S. Reddy, Colon tumor promotion by
phenylhexyl isothiocyanate in male F344 rats, Proc. Am. Assoc. Cancer Res., 36 (1995) 124.
[164] G.D. Stoner, J.C. Siglin, M.A. Morse, D.H. Desai, S.G. Amin, L.A. Kresty, A.L. Toburen, E.M.
Heffner and D.J. Francis, Enhancement of esophageal ~rcinogenesis in male F344 rats by dietary
phenyIhexy1 isothiocyanate, Carcinogenesis, 16 (I 995) 2473-2476.
(1651 Y. Zhang, T.W. Kensler, C.-G. Cho, G.H. Posner and P. Taiatay, Anticarcinogenic activities of
sulforaphane and structurally related synthetic norbornyl isothiocyanates, Proc. Natl. Acad. Sci.
USA, 91 (1994) 3147-3150.
[166] L. Newfield, A. Goldsmith, H.L. Bradlow and K. Auborn, Estrogen metabolism and human
papilloma~Ns-indu~d
tumors of the larynx: chemo-prophylaxis with indole-3-carbinol, Anticancer Res., 13 (1993) 337-342.
[167] R.H. Dashwood, A.T. Fong, D.E. Williams, J.D. Hendricks and G.S. Bailey, Promotion of
aflatoxin B, carcinogenesis by the natural tumor modulator indole-3-carbinol: influence of dose,
duration, and intermittent exposure on indole-3-carbinol promotional potency, Cancer Res., 51
(1991) 2362-236s.
[I681 G.S. Bailey, J.D. Hendricks, D.W. Shelton, J.E. Nixon and N.E. Pawlowski, Enhancement of
carcinogenesis by the natural anticarcinogen indole-3-carbinol, J. Natl. Cancer Inst., 78 (1987)
931-934.
[169] B.C. Pence, F. Buddingh and S.P. Yang, Multiple dietary factors in the enhancement of
dimethylhydrazine carcinogenesis: main effect of indole-3-carbinol, J. Nat1 Cancer Inst., 77 (1986)
269-276.
[170] J.J. Jang, K.J. Cho, Y.S. Lee and J.H. Bae, Modifying responses of ally1 sulfide, indole-3-carbinol
and germanium in a rat multi-organ carcinogenesis model, Carcinogenesis, 12 (1991) 691-695.
[171] D.J. Kim, K.K. Lee, B.S. Han, B. Ann, J.H. Bae and J.J. Jang, Biphasic modifying effect of
indole-3-carbinol on diethylnitrosamine-induced
preneoplastic glutathione S-transferase placental
form-positive liver cell foci in Sprague-Dawiey rats, Jpn. J. Cancer Res., 85 (1994) 578-583.
[I721 L.W. Wattenberg and W.D. Loub, Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles, Cancer Res., 38 (1978) 1410-1413.
[173] T. Tanaka, Y. Mon, Y. Morishita, A. Hara, T. Ohno. T. Kojima and H. Mon, Inhibitory effect
of sinigrin and indole-3-carbinol on diethylnitrosamine-indu~d
hepatocarcinogenesis in male
ACljN rats, Carcinogenesis, 11 (19901 1403-1406.
11741T. Tanaka, T. Kojima, Y. Morishita and H. Mon, Inhibitory effects of the natural products
indole-3-~arbinol and sin&in during initiation and promotion phases of 4-nitroquinoline 1-oxideinduced rat tongue carcinogenesis, Jpn. J. Cancer Res., 83 (1992) 835-842.
11751 L.W. Wattenberg, Inhibition of neoplasia by minor dietary constituents, Cancer Res., 43 (1983)
2448s-2453s.
11761 L.W. Wattenberg, H.W. Schafer, L. Jr. Waters and D.W. Davis, Inhibition of mammary tumor
formation by broccoli and cabbage, Proc. Am. Assoc. Cancer Res., 30 (1989) 181.
[I771 G.S. Stoewsand, J.L. Anderson and L. Munson, Protective effect of dietary Brussels sprouts
against mammary carcinogenesis in Sprague-Dawley rats, Cancer Lett., 39 (1988) 199-207.

12x

D.T.H.

~erhoeven et al. / Chemise-~i~l~~icul ~nter~~t~ons103 (1997) 79-129

[178] J.N. Boyd, J.G. Babish and G.S. Stoewsand, Modification by beet and cabbage diets of aflatoxin
B,-induced rat plasma a-foetoprotein elevation, hepatic tumorigenesis, and mutagenicity of urine,
Food Chem. Toxicol., 20 (1982) 47-52.
[I791 C. Srisangam, D.G. Hendricks, R.P. Sharma, D.K. Salunkhe and A.W. Mahoney, Effects of dietary
cabbage on the tumorigenicity of 1,2-dimethylhydrazine in mice, J. Food Saf., 4 (1980) 23% 245.
[180] E. Bresnick, D.F. Birt, K. Wolterman, M. Wheeler and R.S. Markin, Reduction in mammary
tumorigenesis in the rat by cabbage and cabbage residue, Carcinogenesis, 11 (1990) 1159-1163.
[I811 E.M. Scholar, K. Wolterman, D.F. Birt and E. Bresnick, The effect of diets enriched in cabbage
and collards on murine pulmonary metastasis, Nutr. Cancer, 12 (1989) 121- 226.
[I821 J.J. Michnovicz and H.L. Bradlow, Induction of estradiol metabolism by dietary indole-3-carbinol
in humans, J. Nat1 Cancer Inst., 82 (1990) 947-949.
[IS31 J.J. Michnovicz and H.L. Bradlow, Altered estrogen metabolism and excretion in humans following
consumption of indole-3-~rbinol, Nutr. Cancer, 16 (1991) 59-66.
I1841 H.L. Bradlow, J.J. Michnovicz, M. Halper, D.G. Miller, G.Y C. Wongand M.P. Osborne, Long-term
responses ofwomen to indole-3-~rbinol or a high fiber diet, Cancer Epidemiol Biomarkers and Prev.,
3 (1994) 591-59s.
[IS51 H. Verhagen, H.E. Poulsen, S. Loft, G. van Poppel, MI. Willems and P.J. van Bladeren, Reduction
of oxidative DNA-damage in humans by Brussels sprouts, Carcinogenesis, 16 (1995) 969-970.
[186] J.J. Bogaards, H. Verhagen, MI. Willems, G. van Poppel and P.J. van Bladeren, Consumption of
Brussels sprouts results in elevated a-class glutathione S-transferase levels in human blood plasma,
Carcinogenesis, 15 (1994) 1073-1075.
[187] E.J. Pantuck. C.B. Pantuck, W.A. Garland, B.H. Mm, LW. Wattenberg, K.E. Anderson, A. Kappas
and A.H. Conney, Stimulatory effect of Brussels sprouts and cabbage on human drug metabolism,
Clin. Pharmacol. Ther., 25 (1979) 88-95.
[I881 W.A. Nijhoff, T.P.J. Mulder, H. Verhagen, G. van Poppel and W.H.M. Peters, Effectsofconsumption
of Brussels sprouts on plasma and urinary glutathione S-transferase class-* and -R in humans,
Carcinogenesis, 16 (I 995) 9555958.
[IS91 W.A. Nijhoff, FM. Nagengast, M.J.A.L. Grubben, J.B.M.J. Jansen, H. Verhagen, G. van Poppel
and W.H.M. Peters, Effects of consumption of Brussels sprouts on intestinal and lymphocytic
glutathione and glutathione S-transferases in humans, Carcinogenesis, 16 (1995) 21X-2128.
[190] S. Yannai, H.L. Bradlow, J. Westin and E.D. Richter, Consumption ofcruciferous vegetables-probable protection against breast cancer, in: H. Kozlowska, J. Fornal and Z. Zduflczyk (Eds.), Proc.
of the Int. Conference Euro Food Tox IV Bioactive substances in food of plant origin, 2, Dietary
Cancer Prevention, Centre for Agrotechnology and Veterinary Sciences, Olszytn, Poland, 1994, pp.
480-483.
[I911 M.A. Kall, 0. Vang and J. Clausen, Effects of dietary broccoli on human in oivo drug metabolizing
enzymes: evaluation of caffeine, oestrone and chlorzoxazone metabolism, Carcinogenesis, 17 (1996)
793-799.
[I921 K. Vistisen, HE. Poulsen and S. Loft, Foreign compound metabolism capacity in man measured
from metabolites of dietary caffeine, Carcinogenesis, 13 (1992) 1561- 1568.
[ 1933 K. Vistisen, S. Loft and H.E. Poulsen, Cytochrome P450 1A2 activity in man measured by caffeine
metabolism: effect of smoking, broccoli and exercise, Adv. Exp. Med. Biol., 283 (1991) 407-411.
[I941 C. Nastruzzi, R. Cortesi, E. Esposito, E. Menegatti, 0. Leoni, R. Ion and S. Palmieri, In uitrocytotoxic
activity of some glucosinolate-derived products generated by myrosinase hydrolysis, J. Agric. Food
Chem., 44 (1996) 1014-1021.
[195] A. Adesida, L.G. Edwards and P.J. Thornalley, Inhibition of human leukaemia 60 cell growth by
mercapturic acid metabolites ofphenylethyl isothiocyanate, Food Chem. Toxicol., 34 (1996) 385-392.
[196] S.S. Hecht, F.-L. Chung, J.P. Richie Jr., S.A. Akerkar, A. Borukhova, L. Skowronski and SC.
Carmella, Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen
in smokers, Cancer Epidemiol. Biomarkers and Prev., 4 (1995) 8777884.
[I971 R. Yu, J.-J. Jiao, J.-L. Duh, T.-H. Tan and A.-N.T. Kong, Phenethyl isothiocyanate, a natural
chemopreventive agent, activates c-Jun N-terminal kinase I, Cancer Res., 56 (1996) 2954-2959.
[I981 P.H. Jellinck. H.L.J. Makin, D.W. Sepkovic and H.L. Bradlow, Influence of indole carbinols and
growth hormone on the metabolism OfCandrostenedione by rat livermicrosomes, J. Steroid Biochem.
Molec. Biol., 46 (1993) 391-798.

11991 J. Schulze, W. Schlager, R. Wtinsch and E. Richter, Metabolism

of 4-(methylnitr~samino)-l-(3pyridyl)-I -butanone (NNK) by hamster, mouse and rat intestine: relevance of species differences,
Carcinogenesis, I7 (1996) 1093- 1099.
[200] D.T.H. Verhoeven, R.A. Goldbohm, G. van Poppel, H. Verhagen and P.A. van den Brandt,
Epidemiological studies on brdssica vegetables and cancer risk: a review, Cancer Epidemiol..
Biomarkers and Prev.. 5 (1996) 733-748.
[2Ol] T. Yamaguchi, Mutagenicity of isothiocyanates, isocyanates and thioureas on Saln7ontdlu
typhimurium,
Agric. Biol. Chem., 44 (1980) 3017-3018.
[202] T. Neudecker and D. Henschler, Ally1isothiocyanate ismutagenic in Salmonellu t,@zimurirmt, Mutat.
Res., 156 (1985) 33.-37.
(2031 A. Kasamaki. H. Takahashi, N. Tsumura, J. Niwa, T. Fujita and S. Urasawa, Genotoxicity of
flavoring agents, Mutat. Res., 105 (1982) 3877392.
[204] C. Sasagawa and T. Matsushima, Mutagen formation on nitrite treatment of indole compounds
derived from ~ndole-8iucosino~~te, Mutat. Res., 250 (1991) 169- 174.
[ZOS]S.R.R. Musk, M.N. ~reobrazhenskaya, G.A. Belitsky, A.M. Korolev. T.A. Lytcheva, I.A. Khitrovo
and IT. Johnson, The clastogenic and mutagenic effects of ascorbigen and I-methylascorbigen,
Mutat. Res., 323 (1994) 69-74.
[206] H.G.M. Tiedink, J.A.R. Davies, L.W. van Broekhoven, H.J. van der Kamp and W.M.F. Jongen,
Formation of mutagenic N-nitroso compounds in vegetable extracts upon nitrite treatment: a
comparison with the glucosinolate content, Food Chem. Toxicol., 26 (1988) 947-954.
[207] S.R.R. Musk, T.K. Smith and LT. Johnson. On the cytotoxicity and genotoxicity of ally1 and
phenethyl isothiocyanates and their parent glucosinolates sinigrin and gluconasturtim. Mutat. Res..
348 (1995) 19--23.
[ZOS]S.R.R. Musk, S.B. Astley, S.M. Edwards, P. Stephenson, R.B. Hubert and LT. Johnson, Cytotoxic
and clastogenic effects of benzyl isothiocyanate towards cultured mammalian cells, Food Chem.
Toxicol., 33 (1995) 31 -37.
[209] S.R.R. Musk and LT. Johnson, The clastogenic effects of isothiocyanates, Mutat. Res., 300 (1993)
111-117.
[210] A. Kasamaki, T. Yasuhara and S. Urasawa, Neoplastic transfo~ation
of Chinese hamster cells in
vitro after treatment with flavoring agents, J. Toxicol. Sci., 12 (1987) 3833396.
[211] J.K. Dunnick, J.D. Prejean, J. Haseman, R.B. Thompson, H.D. Giles and E.E. McConnell,
Carcinogenesis bioassay of ally1 isothiocyanate, Fundam. Appl. Toxicol., 2 (1982) I I4 .- 120.
[212] H.G.M. Tiedink, A.M. Hissink, SM. Lodema, L.W. van Broekhoven and W.M.F. Jongen. Several
known indole compounds are not important precursors of direct mutagenic N-nitroso compounds
in green cabbage, Mutat. Res., 232 (1990) 199-207.
[213] H.G.M. Tiedink, GE. Malingre, L.W. van Broekhoven, W.M.F. Jongen, J. Lewis and G.R. Fenwick,
Role of glucosinolates in the formation of ,Y-nitroso compounds, J. Agric. Food Chem.. 39 (1991)
922-926.
[214] H.-J. Lewerenz, D.W.R. Bleyl and R. Plass, Subacute oral toxicity study of benzyl isothiocyanate
in rats, Nahrung, 36 (1992) 190-198.
12151 K. Nishie and ME. Daxenbichler, Toxicology of glucosinolates, related compounds (nitriles,
R-goitrin, isoth~ocyanates) and vitamin II found in cruciferae. Food Cosmet. Toxicol., 18 (1980)
159-172.
[216] R. Mawson, R.K. Heany, Z. Zdunczyk and H. Kozlowska, Rapeseed meal-glucosinolates and their
antinutritional effects. Part 3. Animal growth and performance, Nahrung, 38 (1994) 167-.-l77.
12171 R. Mawson, R.K. Heany, 2. Zdunczyk and H. Kozlowska, Rapeseed meal-glucosinoiates and their
antinutritional effects. Part 4. Goitrogenicity and internal organs abnormalities in animals, Nahrung.
38 (1994) 178-191.
[218] L. Nugon-Baudon, S. Rabot, 0. Szylit and P. Raibaud, Glucosinolates toxicity in growing rats:
interactions with the hepatic detoxification system, Xenobiotica, 20 (1990) 2233230.
[219] G. van Poppel, WI. Willems and H. Verhagen, Thyroid function after consumption of Brussels
sprouts: controlled experiment in humans. TN0 Nutrition and Food Research Institute, Zeist.
Netherlands. 1993.
[ZZO]M. McMill~, E.A. Spinks and G.R. Fenwick. Preliminary observations on the effect of dietary
Brussels sprouts on thyroid function, Hum. Toxicol., 5 (1986) 15. 19.

Das könnte Ihnen auch gefallen